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Abstract 
Chromatographic Analysis and Separation of Short RNA Oligonucleotides with Novel 
Liquid Chromatography Methods 
Mirlinda Biba 
Joe P. Foley, PhD 
Christopher J. Welch, PhD 
 
Synthetic oligonucleotides have become increasingly important as part of new 
developments in the use of antisense and small interfering ribonucleic acid (siRNA) as 
potential therapies for the treatment of various different diseases.  The development of 
analytical methods for the sensitive and quantitative analysis and separation of 
oligonucleotides is an essential part for the advancement of this research area.  A typical 
oligonucleotide therapeutic sample is a short RNA-based oligonucleotide with about 21-
mer length (~7-8 kDa), and with possible chemical modifications prepared by chemical 
synthesis using an automated synthesizer.  Due to their relatively large sizes compared to 
typical small-molecule compounds, oligonucleotides can be difficult to analyze with 
traditional analytical methods.  There are many different analytical techniques reported 
for the analysis and separation of oligonucleotides, including capillary gel electrophoresis 
(CGE), anion-exchange high performance liquid chromatography (AEX-HPLC), and ion-
pair reversed-phase liquid chromatography (IP-RPLC).  In these research studies, existing 
liquid chromatography methods for the separation of oligonucleotides were evaluated for 
improved separations.  New and novel approaches were also explored for more efficient 
analysis and separation of oligonucleotides. 
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Chapter 1: Introduction to Liquid Chromatography 
 
1.1 A brief history of chromatography 
 
Chromatography is a separation method in which the components to be separated 
are distributed between two phases, one of which is stationary (the stationary phase) and 
one of which moves through the chromatographic bed (the mobile phase).  The different 
components of the mixture, usually referred to as analytes, travel with different speeds 
across the chromatographic bed, allowing them to separate.  The separation process is 
based on the differential partitioning between the mobile and stationary phases.  Different 
compounds have different partition coefficients resulting in different retentions on the 
stationary phase and causing them to separate.  Time-based detection of compounds 
eluting from the column provide a chromatogram, a graphical record of the separation 
represented as concentration of the analyte separated (typically units of detection) vs. the 
retention time (Figure 1.1) [1]. 
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Figure 1.1 Principles of adsorption chromatography separation. Application of a mixture 
of compounds to a column containing a chromatographic stationary phase and elution 
with mobile phase leads to chromatographic resolution of compounds having differing 
adsorption on the stationary phase. Time-based detection of compounds eluting from the 
column provide a chromatogram, a graphical record of the separation [1]. 
 
 
 
Chromatography was first discovered by the Russian botanist Mikhail Tswett in 
1903 when he produced a colorful separation of plant pigments, such as chlorophyll, 
using a column of calcium carbonate [2, 3].  The chromatographic separation method, 
however, was not used among scientists and very few chromatography studies were 
reported during the first 40 years from its discovery [4].  This changed in the 1940s when 
A.J.P. Martin and R.L.M. Synge at Cambridge University in the United Kingdom (UK) 
discovered partition chromatography  for which they were awarded the Nobel Prize in 
1952 [5].  Their work established the principles of partition chromatography and laid a 
solid foundation for the rapid growth of many chromatographic techniques that followed 
later. 
Initially, chromatography development was primarily based on gas 
chromatography (GC) [6] and also as thin-layer chromatography (TLC) [7] and 
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countercurrent (CCC) or liquid-liquid [8, 9] chromatography.  Liquid chromatography in 
its modern form and its enormous fast growth afterwards can be attributed to the 
pioneering work of Prof. Horvath at Yale University.  During the 1960s, Prof. Horvath, 
who had previously worked on the development of gas chromatography columns, 
experimented with small glass beads with a porous layer on their surface to help with the 
mass transfer between the liquid mobile phase and the solid surface of the column.  Since 
the columns packed with the small beads developed a high pressure to the liquid flow, 
Prof. Horvath built an instrument that could handle this high pressure of the liquid 
through the column [10].  This led to the discovery of high-performance liquid 
chromatography (HPLC), which was introduced by Prof. Horvath in 1970 [11].  
Following its introduction in 1970s, HPLC research went through a tremendous 
growth with thousands of papers published by the 1980s.  By the 1990s, HPLC was 
considered a mature technique, where the separation process was mostly understood, and 
there were suitable equipment and columns available.  New specialized applications of 
HPLC continued to develop, and many research studies in this area are still on-going.  
Today, HPLC is one of the most widely used analytical techniques [12, 13]. 
 
1.2 Chromatography classification 
 
The nature of the stationary and the mobile phases is the basis for the 
classification of chromatographic techniques.  The mobile phase could be either a liquid 
or a gas, and chromatography can be subdivided into liquid chromatography (LC) or gas 
chromatography (GC).  There are two other modes that use a liquid mobile phase, but the 
4 
 
nature of the liquid transport through the porous stationary phase can be either by 
capillary forces such as in TLC [7], or electroosmotic flow such as in capillary 
electrochromatography (CEC) [14, 15].  Another mode of chromatography is 
supercritical fluid chromatography (SFC) [16].  In SFC, a supercritical fluid, such as 
carbon dioxide under elevated temperature and pressure, is used as the mobile phase. 
The next classification step is based on the nature of the stationary phase.  In gas 
chromatography, the stationary phase could be either a liquid or solid, and gas 
chromatography can be gas-liquid chromatography (long capillary coated with a thin film 
layer of viscous liquid) and gas-solid chromatography (long capillary with thin porous 
layer on the walls or packed columns with porous particles) [12].  Similarly, in liquid 
chromatography, the stationary phase could be either a liquid or solid, and liquid 
chromatography can be liquid-liquid chromatography or liquid-solid chromatography.  
Liquid chromatography in general refers to liquid-solid chromatography and this can be 
further separated based on the type of interactions of the analyte with the stationary phase 
surface.  LC can be subdivided into normal-phase (NP), reversed-phase (RP), ion-
exchange (IEX), size-exclusion chromatography (SEC), and affinity chromatography.  
Each LC mode is described in more details in section 1.4. 
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Figure 1.2 Classification of chromatography modes [12]. 
 
 
 
Chromatography can also be analytical or preparative.  Analytical 
chromatography is usually performed with smaller amounts of sample and it is used for 
measuring the relative proportions of analytes in a mixture.  Preparative chromatography 
is usually performed with larger amounts of sample ranging from milligram quantities to 
kilograms to large-scale production of tons.  Preparative chromatography is a form of 
purification where different components of a mixture can be isolated for further use.  It is 
also important to note that every analytical scale chromatography can be performed in 
preparative scale.  One of the main differences between analytical and preparative 
chromatography is column overloading in preparative chromatography.   This results in 
deformed and moving peaks as a consequence of a shift in the nonlinear range of the 
adsorption isotherms.  Typically the injection amount is increased until the two peaks 
touch, also referred to as touching-band optimization [17].  Preparative chromatography 
principles have been reported by Guiochon and co-workers [18-21]. 
Chromatography
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NP RP IEX SEC
Gas-Liquid Gas-Solid
Affinity
6 
 
1.3 Chromatography fundamentals and theory 
 
There are two major aspects of HPLC theory, kinetic and thermodynamic.  The 
kinetic factors are responsible for the band broadening (i.e., efficiency) and determine the 
width of chromatographic peak whereas the thermodynamic factors are responsible for 
the analyte retention on the column (i.e., selectivity) and determine the position of the 
peak on the chromatogram.  Both theoretical aspects are important in a chromatographic 
separation [12]. 
Four major parameters are used to describe a chromatographic separation:  
retention factor (k), column efficiency (N), resolution (Rs), and selectivity (α). 
 
1.3.1 Retention factor k 
 
For a given solute, the retention factor k is defined as the time that a solute spends 
in the stationary phase (ts) relative to the time that it spends in the mobile phase (tm), i.e., 
k = ts/tm.  The retention factor of a solute may also be expressed more fundamentally as 
the product of the solute’s inherent affinity for the stationary phase relative to the mobile 
phase (Kc, the distribution constant) and the ratio of the volumes of the stationary phase 
and the mobile phase (Vs/Vm). 
k = Kc (Vs/Vm)     (1.1) 
The retention time (tR) of a solute can be defined as the elapsed time between the 
sample injection and recording of the peak maximum, and is equivalent to the quotient of 
the distance traveled (column length L) and the solute’s average linear velocity ν. 
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tR = L/v     (1.2) 
Similarly, the retention time of the solvent peak (or the retention time of a non-
retained component) is: 
                (1.3) 
where νavg is the average mobile-phase velocity.  Also referred to as the dead-time or 
holdup time, t0 is the time required by the mobile phase to pass through the column.  The 
value of t0 can often be estimated from a visual inspection of the initial portion of a 
chromatogram, as the first baseline disturbance (Fig 1.3).  This t0 baseline disturbance is 
due to refractive index (RI) differences for the sample solvent vs. the mobile phase.  
However, if the sample is dissolved in the mobile phase, which is often the preferred 
choice, then a t0 peak may not be observed in the chromatogram.  In this case, a solute 
that is unretained and readily detected (e.g. uracil in RPLC) is injected to determine t0 
[22].   
Alternatively, for column packed with fully-porous particles, t0 can be estimated 
from the column dimensions and flow rate using the following equation [22]: 
         
   
   
 
 
      (1.4) 
where L is the column length in mm, dc is the column inner diameter in mm, F is the flow 
rate in mL/min, and t0 is in minutes.   
Similarly, in terms of volume, the column dead-volume V0 is related to t0 
according to the following equation: 
              
     
     (1.5) 
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The dead-volume V0 represents the total volume of mobile phase inside the column, 
including both inside and outside of the column particles.  The time t0 then can be 
considered as the time required for emptying the mobile phase that was originally present 
in the column.  Similarly, the retention volume VR=tRF, where F is the mobile phase flow 
rate in mL/min. 
In general, if two compounds have different retention times, then they will be 
separated.  As shown in Figure 1.3, the retention time tR = t0 + t’R, or the sum of dead 
time t0 and the reduced retention time or adjusted retention time t’R.  Since t0 is identical 
for all eluted compounds (i.e. the mobile phase residence time), t’R is the stationary phase 
residence time and it is different for each separated compound.  Therefore, the retention 
factor k can be expressed with the following equation: 
  
  
 
  
 
     
  
     (1.6) 
The retention factor is dimensionless and independent of the mobile phase flow rate and 
column dimensions, and it represents the molar ratio of the compound in the stationary 
phase and the mobile phase.  Equation 1.6 can be used to calculate k values for each peak 
in the chromatogram.   
9 
 
 
Figure 1.3 Analyte retention descriptors [12]. 
It is also important to note that temperature is an important variable and it has 
significant effects on the values of retention factor k.  The dependence of the retention 
factor on temperature can be determined using the Van’t Hoff equation [23]: 
        
 
  
      (1.7) 
where A and B are temperature independent constants for a given solute with other 
conditions unchanged, and TK is the temperature.  The retention factor k usually 
decreases with increasing temperature by about 1-2% per °C, although in a few cases the 
opposite can occur where the retention increases with an increase in temperature due to 
different reasons, such as the ionization of a solute or solute molecular conformation 
changes with increasing temperature.  
From a more practical standpoint, values of the retention factor k between 1 and 
10 are preferred for various reasons.  The retention factor goal for k ≤10 for all peaks is 
10 
 
because this corresponds to narrower peaks that are better detected, as well as short run 
times so that more samples can be analyzed each day.  On the other hand, values of k < 1 
can result in poorly resolved peaks that elute close to the dead time t0.  The retention 
factor k range, however, can be optimized for each particular separation depending on the 
specific separation criteria. 
 
1.3.2 Column efficiency N 
 
The column efficiency (or number of theoretical plates) is a measure of the degree 
of band-broadening and it is defined by the plate number N: 
     (
  
 
)
 
       (1.8) 
where tR is the analyte retention time and w is the peak width measured at the baseline.   
Peak width can be measured more precisely at half-height w0.5, and plate number 
N then can be calculated with 
       (
  
    
)
 
     (1.9) 
Equations 1.8 and 1.9 can be used to correctly calculate plate number only if the peak has 
a Gaussian shape.  In most real-life chromatograms, however, peaks do not have 
Gaussian shapes and approximately correct values can be obtained by using the Foley-
Dorsey equation [24]: 
  
             
 
(
 
 
)     
    (1.10) 
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where w0.1 is the peak width at 10% of the peak height and the quantities of A and B are 
related to the peak asymmetry where A describes the distance from the peak front to the 
maximum (at 10% peak height) and B describes the distance from the peak maximum to 
the peak end (at 10% peak height). 
Plate number N can also be described by the following: 
  (
 
 
)       (1.11) 
where H is the column plate height and L is the column length.  The plate height H is a 
measure of column efficiency per unit length of column and for a given linear velocity it 
is constant for columns that differ in length and inner diameter but have the same type 
and size of the stationary phase particle.  Therefore, by increasing the column length 
(such as replacing a 150 mm long column with a 250 mm column) the column efficiency 
will increase. 
The more efficient the analyte exchange between the two phases, the greater the 
number of plates, and the better the separation.  Efficiency is a property of the column 
and it mainly depends on the properties of the column packing bed, molecular diffusion, 
flow rate, etc.  The smaller the particles and the more uniform the packing in the column, 
the higher the column efficiency.  Therefore, by selecting smaller particles the efficiency 
can be improved when operating at optimum values of flow rate (Fopt).  The pressure drop 
across the column, however, also increases for smaller particles (and higher flow rates), 
and ultra-high pressure liquid chromatography (UHPLC) instruments with pressures of 
10,000 to 15,000 psi or higher need to be utilized.  The pressure (in psi) for a packed 
column can be estimated by using the following equation [13]: 
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      (1.12) 
or from equation 1.4 and 1.12 
   
       
  
   
      (1.13) 
where L is the column length (in mm), t0 is in minutes, F is the flow rate (in mL/min), dc  
is the column internal diameter (in mm), dp is the particle diameter (in µm), and η is the 
viscosity of the mobile phase in cP (viscosity values as a function of mobile phase 
composition and temperature) [25]. 
The effects of particle size, pressure drop, and column permeability can be 
illustrated using kinetic plots known as the Poppe plots [26], where the time required to 
generate one theoretical plate (t0/N) is plotted against the value of N.  The “time per 
plate” increases as the values of N increase, and these plots show the advantage of small 
particles when certain values of N are required. 
 
1.3.2.1 Band broadening processes that determine values of N 
 
The peak width w, retention time tR, and (optionally) the asymmetry factor (B/A) 
of the peak of a suitable compound provide an estimate of the plate number N of the 
column (Equations 1.8, 1.9 and 1.10).  Different processes within and outside of the 
column contribute to the final peak width w (Figure 1.4) [13].   
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Figure 1.4 Illustration of various contributions to band broadening during HPLC 
separation.  Molecules of solute represented by ○ (before migration) and ● (after 
migration); - - - > indicates movement of a solute molecule [13]. 
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First, following sample injection, but before the sample enters the column, 
molecules will occupy a small volume (Figure 1.4a).  This extra-column contribution to 
band width can be ignored, depending on the characteristics of the separation instrument.  
The observed peak volume Vp in a chromatogram is influenced by band broadening 
inside the column Vp0, as well as by other system-related factors, such as the volume 
contributions from the injection process Vs, the tubing and fittings used to plumb the 
instrument after the injector Vpl, the detector cell volume Vdt, and the data-system time-
constant Vds.  These various contributions add according to the following equation [13] to 
give the overall peak volume Vp. 
   (   
     
     
     
     
 )
   
   (1.14) 
For a given method, the extra-column effects will be constant, but the column 
broadening Vp0 will vary for each solute.  Therefore, the use of column conditions that 
generate smaller peak volumes Vp0, such as short, narrow-diameter, small particle 
columns will make extra-column effects more important.  This is especially the case 
when using sub-2-micron columns, where the instrument has to be specially designed to 
minimize all of these extra-column effects. 
Next, the longitudinal diffusion (also known as the B-term in the Van Deemter 
equation 1.15) of solute molecules along the column causes band broadening with time 
(Figure 1.4b).  The contribution to band broadening from longitudinal diffusion is 
inversely related to linear velocity (or flow rate).  Eddy dispersion (also known as the A-
term in the Van Deemter equation 1.15) is another contribution to band broadening 
(Figure 1.4c).  As solute molecules move through the column between particles, some 
molecules move more slowly between narrower paths and other molecules move more 
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quickly between wider paths.  This contribution is independent on the flow rate, and 
depends only on the arrangement and sizes of the particles within the column.  As a 
result, the band broadening due to eddy dispersion increases for poorly packed columns.  
The solute mass transfer within the flowing mobile-phase also contributes to band 
broadening (Figure 1.4d).  This is due to the faster flow of the stream center, and as the 
flow rate increases, the center of the stream moves relatively faster, contributing to band 
broadening.  This band broadening contribution is flow rate dependent.  Similarly, the 
solute mass transfer in the stagnant mobile phase contributes to band broadening within 
the column (Figure 1.4e).  Some sample molecules will move further into a particle pore 
and spend a longer time before leaving the pore (such as molecule i in Figure 1.4e), while 
other molecules will move a shorter distance into the particle and spend less time before 
leaving the particle (molecule j).  This band broadening contribution is also flow rate 
dependent.  The mobile phase and stationary phase mass transfer described above is also 
known as the C-term in the Van Deemter equation.  Finally, when the band leaves the 
column and passes through the detector (Figure 1.4f), there is some additional extra-
column band broadening (Vdt term in equation 1.14). 
The following equation can be derived from each of the band broadening 
contributions to the peak width w: 
H = A + B/F + CF     (1.15) 
where A, B, and C are constants for eddy dispersion, longitudinal diffusion, and mobile 
phase plus stationary phase mass transfer, respectively, and F is the flow rate, for a 
particular sample and column.  If the values of F are replaced by the mobile phase 
velocity ν, the van Deemter equation is obtained: 
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H = A + B/ν + Cν     (1.16) 
A plot of H versus ν is referred to as van Deemter plot (Figure 1.5).  The van 
Deemter plots are useful in understanding sources of band broadening and how to 
minimize them in a chromatographic separation. 
 
 
 
Figure 1.5 Van Deemter plot showing contribution of individual band-broadening terms 
[12]. 
 
 
 
In equation 1.16 it is assumed that all four contributions (eddy dispersion, 
longitudinal diffusion, mobile phase and stationary phase mass transfer) to the peak width 
w are independent of each other.  However, for eddy dispersion and mobile phase 
transfer, there is remixing of the two flow streams and these two processes can be treated 
as a single band broadening contribution.  Additionally, because eddy dispersion does not 
vary with flow rate, while mobile-phase mass transfer does, experimental studies have 
shown that the dependence of A term (eddy dispersion plus mobile phase mass transfer) 
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will vary with 1/3 power of the flow rate, therefore the following equation can be 
obtained [13]: 
H = AF
1/3 
+ B/F + CF     (1.17) 
where A, B, and C are coefficients for eddy dispersion plus mobile phase mass transfer, 
longitudinal diffusion, and stationary phase mass transfer, respectively.  The above 
equation can then be restated as the Knox equation [27]: 
h = Aυ1/3 + B/υ + Cυ     (1.18) 
where values of the coefficients can be assumed as A =1, B = 2, and C = 0.05 for an 
“average” separation [13].  Also, h is the reduced plate height 
h = H / dp      (1.19) 
and υ is the reduced velocity 
υ = ue dp / Dm      (1.20) 
where ue is the interstitial velocity of the mobile phase, dp is the particle diameter, and Dm 
is the solute diffusion coefficient.  A plot of h versus υ is referred to as a Knox plot 
(Figure 1.6). 
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Figure 1.6 Knox plots.  (a) Plot of reduced plate height h versus reduced velocity υ with 
A=1, B=2, and C=0.05.  The total plate height h is shown as a solid curve; the three 
contributions to h are shown as dashed or dotted curves.  (b)  Effect of a change in solute 
molecular weight (6000 vs. 200 Da) or temperature (80 °C vs. 30 °C) on h versus flow 
rate [13]. 
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1.3.3 Resolution Rs 
 
The separation of two peaks in a chromatogram is described by their resolution 
Rs, where the resolution is calculated by the difference in retention times divided by the 
average peak widths: 
    
           
       
     (1.21) 
where tR1 and tR2 are the retention times and wb1 and wb2 are the peak widths measured at 
baseline for peaks 1 and 2, respectively.  Increased resolution results from a greater 
difference in peak retention times and/or narrower peaks.  For two peaks of similar size, 
baseline resolution corresponds to Rs > 1.5.  However, peak tailing can impact resolution, 
and in a case where there is peak tailing, resolution of greater than 2 may be necessary to 
obtain baseline resolution. 
During LC method development, it can be useful to calculate resolution in terms 
of retention, selectivity, and efficiency.  There have been many different versions of 
resolution equations proposed for isocratic elution (i.e., elution using a fixed mobile 
phase composition) conditions, with the following equations offering the most accurate 
prediction, assuming that the plate count N among the peaks being compared are 
comparable (within 20%) [28]: 
   (
√ 
 
)      
  
      
    (1.22) 
   (
√ 
 
)  
   
 
  
  
      
    (1.23) 
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where kavg = (k1 + k2) / 2.  In cases where the plate counts differ significantly but not 
more than a factor of 4, the following empirical equation is recommended: 
   (
√  
 
)  
   
 
  
    
      
    (1.24) 
where the empirical     √    . 
 
1.3.4 Selectivity α 
 
Selectivity (α), also referred to as the separation factor, is defined as  
  
  
  
      (1.25) 
where k2 and k1 are the retention factors for peaks 2 and 1, respectively.  According to 
resolution equations 1.22 to 1.24, resolution can be improved by varying retention factor 
k, selectivity α, or column efficiency N, but improving the selectivity is the most 
powerful option.  
If needed, the differences in the free energy of transfer of two solutes from the 
mobile phase to the stationary phase can be obtained from the selectivity as follows [29]: 
∆(∆G˚) = - RT ln α     (1.26) 
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1.3.5 Peak capacity 
The peak capacity of a separation refers to the total number of peaks that can fit 
into a chromatogram, when every peak is separated from adjacent peaks with resolution 
Rs=1.  For isocratic separation, peak capacity (PC) is given by the following equation 
[30]: 
     (
    
 
)    
   
  
                 
   
  
   (1.27) 
where tRz is the retention time of the last peak in the chromatogram.  For example, for 
typical separations with k ≤ 20 for the last peak, and values of N of 20,000, the peak 
capacity PC = 108; if the resolution requirement is increased from Rs=1 to Rs=2, then the 
number of peaks that fit in the chromatogram drops to only 47 [13]. 
Peak capacity is especially important for separations of more complex samples 
that contain a very large number of components to be separated.  In these examples, peak 
capacity becomes a much better measure of overall separation than the values of Rs.  
Furthermore, separations of complex samples are usually performed with gradient 
elution, and the concept of peak capacity is more relevant.   
Peak capacity is particularly important in two-dimensional LC (2D-LC) 
separations, where fractions from a first separation are further separated in a second 
separation, and in this case the peak capacity for the two-dimensional separation will be 
equal to the product of the peak capacities from each dimension [31].  For example, if the 
PC=100 for each individual separation, then the peak capacity for the 2D-LC separation 
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will be PC = 100 x 100 = 10,000, showing the power of 2D-LC technique for separating 
complex mixtures that contain hundreds or thousands of components. 
 
1.3.6 Gradient elution 
Isocratic elution is the simplest mode of elution and works well for some samples.  
In isocratic elution, however, it can be difficult to elute all compounds in a reasonable run 
time, especially when dealing with components that have a wide range of retention (or 
peaks with very different values of retention factor k).  Gradient elution refers to a 
continuous change in the mobile phase composition during the separation, i.e., the mobile 
phase becomes increasingly stronger (%B increases) as the separation continues.  The 
mobile phase gradient helps with the faster elution of the more highly-retained 
compounds and allows baseline separation in a shorter run time [32]. 
In gradient elution, the gradient shape, or the way the mobile phase composition 
(%B) changes with time during a gradient run, can be different.  Most gradient 
separations use linear gradients, where the initial and final mobile-phase composition in 
terms of %B are defined within the gradient time (tG), which is the time from start-to-
finish for the gradient.  Other types of gradient elutions include gradient delay, where a 
certain isocratic delay is set before initiating a linear gradient; segmented gradient, where 
two or more different linear gradients are set; step gradients, where a certain isocratic 
elution is quickly stepped to a higher %B and maintained at that mobile phase, etc.   
In isocratic elution, retention is given as a function of ϕ, the volume fraction of 
strong solvent, by the following equation [33]: 
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log k = log kw –Sϕ     (1.28) 
where for a given solute, the quantity kw is the extrapolated value of k for ϕ=0 (water as 
mobile phase), and S ≈ 4 for small molecules < 500 Da [34].  Note that the values of S 
increase with the solute molecular weight M, and the relationship between S and 
molecular weight M can be approximated by:  S ≈ 0.25 M0.5 [35, 36].  A linear gradient 
then can be described by the following: 
         (
 
  
)                 (1.29) 
where %B refers to the mobile phase composition at the column inlet, (%B)0 is the value 
of %B at the start of gradient (time zero), (%B)f  is the value of %B at the finish of the 
gradient, t is any time during the gradient, and tG is the gradient time. 
The fundamental definition of gradient steepness b for a given solute is given by: 
  
     
   
     (1.30) 
and since t0 = Vm/F, then 
                (1.31) 
Based on the gradient steepness definition above, then the retention factor can be 
defined as the following: 
                 
 
  
    (1.32) 
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where (log kw – Sϕ0) for a given gradient and solute is equal to log k at the start of the 
gradient.  A larger value of steepness b corresponds to a faster decrease in retention factor 
k with time, or a steeper gradient.   
The gradient retention factor k
*
 depends on the solute and experimental 
conditions, such as the gradient time tG, flow rate F, column dimensions, and the gradient 
range Δϕ: 
   
       
     
     (1.33) 
where Vm is the column dead-volume (mL).     
For each isocratic or gradient elution, an increase in k or k
*
 corresponds to an 
increase in run time (keeping all other conditions the same).  The effect of k on resolution 
in isocratic condition, i.e. resolution increases for larger values of k, is similar to the 
effect of k
*
 on resolution in gradient elution.  Also, peak widths in isocratic elution 
increase with k, resulting in reduced peak heights.  Similar changes in peak width and 
height are observed in gradient elution as k
*
 is increased. 
The resolution in gradient elution can be defined by the following: 
   (
   
 
)          
  
    
     (1.34) 
and assuming that 2.3 log(α) ≈ (α – 1), for small values of α, then the following 
resolution equation for gradient elution conditions can be obtained: 
   (
 
 
) (
  
    
)               (1.35) 
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where α* is the value of the separation factor α when the band-pair reaches the middle of 
the column (or k ≡ k*), and N* is the value of N when the band reaches the middle of the 
column.   
Regarding the peak capacity in a gradient elution, the same definition applies as in 
isocratic elution, i.e., PC equals the maximum number of peaks that can be fit into a 
given gradient chromatogram with a resolution of Rs = 1 for all adjacent peaks.  Since 
every peak has approximately the same peak width w in a gradient elution, the PC in a 
gradient elution can be expressed as the following: 
     (
  
 
)  
  
 
     (1.36) 
 
1.4 Different types of liquid chromatography 
 
Liquid chromatography is a type of chromatography where the mobile phase is a 
liquid [12, 13, 37].  It is usually performed with a column packed with very small 
particles operating at relatively high pressure, and it is often referred to as high 
performance liquid chromatography (HPLC).  There are two major sub-classes of LC 
based on the polarity of the stationary and mobile phases: normal-phase (NPLC) and 
reversed-phase (RPLC). Other types of liquid chromatography include ion-exchange, ion-
pair RPLC, size-exclusion, and affinity chromatography. 
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1.4.1 Normal-phase liquid chromatography  
 
In NPLC the mobile phase consists of a less-polar solvent, such as hexane or 
heptane mixed with solvents like ethanol, isopropanol or ethyl acetate, with a more polar 
stationary phase, such as unmodified silica.  In general, nonpolar compounds elute first 
under normal phase conditions, with more polar compounds eluting later. NPLC is also 
referred to as adsorption chromatography, where the solute molecules are attached to (or 
adsorbed onto) the surface of particles on the column.  Retention in NPLC is described by 
a displacement process, where the silica surface is covered by a monolayer of solvent 
molecules that are adsorbed from the mobile phase.  In order for a solute molecule to be 
retained, one or more previously adsorbed solvent molecule must be displaced from the 
silica surface.   
The displacement process in NPLC is illustrated in Figure 1.7 (a, b) for a 
relatively nonpolar solute (chlorobenzene) and a weaker, less-polar mobile phase solvent 
(methylene chloride).  In this example, the adsorbed solute molecule is assumed to lie flat 
on the surface of the silica (dotted rectangle) which was originally occupied by two 
molecules of methylene chloride.  Retention differs for a more-polar mobile phase 
solvent such as tetrahydrofuran (THF) and a more polar solute such as phenol as 
illustrated in Figure 1.7 (c, d).  Here the interaction of solvent and solute molecules with 
the surface silanols is stronger (as indicated by the arrows), where there is a 1:1 
interaction of a surface silanol with a polar group on either the solute or solvent. 
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Figure 1.7 Hypothetical examples of solute retention on silica for chlorobenzene (a, b 
non-localized) and phenol (c, d localized).  Mobile phase in (a, b) is a less-polar solvent 
(methylene chloride); mobile phase in (c, d) is a more-polar solvent (THF) [13]. 
 
 
 
Solvent strength in NPLC depends on the polarity of the mobile phase; more polar 
solvents are stronger and result in smaller values of retention factor k.  The strength of a 
solvent mixture, ε can be calculated by using the following equation [38]: 
28 
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      (1.37) 
where ε0A and ε
0
B refer to the solvent strength values for pure solvents A and B, NB is the 
mole-fraction of solvent B in the mobile phase, and nB represents the relative size of 
solvent B, assuming using a fully active adsorbent such as silica.  Elution strength for 
different binary mixtures used for adsorption chromatography on silica is shown in 
Figure 1.8.  
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Figure 1.8 Elution strength of binary mixtures as used for adsorption chromatography on 
silica.  Twelve possible mixtures of hexane, dichloromethane, tert-butylmethyl ether, 
tetrahydrofuran, ethyl acetate and isopropanol [37]. 
 
 
 
NPLC became less commonly used after the introduction of RPLC.  Today, 
NPLC is mainly used for analytical separations by TLC, preparative chromatography for 
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purification of crude samples, analysis of very polar samples that are poorly or not 
retained by RPLC, and the separation of achiral isomers. 
 
1.4.2 Reversed-phase liquid chromatography 
 
In RPLC, a non-polar stationary phase is used with a polar mobile phase (such as 
water).  Silica chemically bonded with octadecyl carbon chains, referred to as C18–
derivatized silica, is the most often used stationary phase in RPLC.  Other shorter alkyl 
chains such as C8 or C4 and other functional groups such as phenyl or cyano can also be 
used.  The more non-polar compounds are generally more retained in RPLC, with polar 
compounds generally eluting earlier.  Reversed-phase HPLC is by far the most popular 
mode of analytical-scale liquid chromatography technique used. 
RPLC is usually a first choice for the separation of neutral and ionic samples, 
typically using a C18 or C8 column and a mobile phase consisting of a mixture of water 
and either acetonitrile (MeCN) or methanol (MeOH).  Other organic solvents such as 
isopropanol (IPA) and tetrahydrofuran (THF) are less often used.  RPLC has many 
advantages, such as the availability of a wide range of columns with different 
dimensions, particle size, and type of stationary phase, which provide efficient and 
reproducible separations.  The solvents used in RPLC are also less flammable or toxic, 
and are more compatible with UV detection below 230 nm allowing increased detection 
sensitivity.  Finally, because RPLC has been the major form of HPLC used since the 
1970s, there is a great deal of practical understanding for this technique and it usually 
provides an easier development for better separations. 
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Retention in RPLC is largely due to the relative interactions between a solute 
molecule and the mobile and stationary phases.  An increase in the volume percentage of 
organic solvent in the mobile phase (%B) makes the mobile phase less polar and 
increases the interactions between solute and solvent molecules, resulting in decreased 
retention for all solute molecules as %B is increased.  Retention in RPLC varies with 
mobile phase %B according to equation 1.28. 
The nature of the RPLC retention mechanism has been the subject of extensive 
research [39-42].  The positioning of the solute molecule within the stationary phase can 
occur in different ways as illustrated in Figure 1.9.  First, solvophobic interaction [39] 
(Figure 1.9a) is when the solute molecule aligns with a ligand group on the stationary 
phase, such as C8 in this example.  Next, adsorption (Figure 1.9b) is when the solute 
molecule is retained at the interface between the stationary and mobile phases.  Finally, 
partition model (Figure 1.9c) is when the solute is distributed between the mobile and 
stationary phases.  Soon after the introduction of RPLC, it was observed that RPLC 
retention (values of k) correlates with partition coefficients P for the distribution of the 
solute between octanol and water (Figure 1.9d), suggesting that a partition process best 
describes the RPLC retention [40].  Overall, many complicated theories regarding the 
adsorption and partition processes in RPLC have been offered.  The exact nature of the 
retention process in RPLC can vary with the type of column, the solute, and the given 
experimental conditions [41, 42]. 
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Figure 1.9 Different possibilities for the retention of a solute molecule in reversed-phase 
chromatography.  (a)  Solvophobic interaction; (b)  adsorption; (c)  partition; (d)  
comparison of RPC retention (k) with octanol-water partition P, sample:  eight amino 
acids, C8 column, aqueous buffer pH 6.7 mobile phase, 70 °C column temperature [13]. 
 
 
 
Selectivity is also an important parameter in RPLC separations, and a change in 
selectivity is the most effective way to improve the resolution (and speed) of a 
chromatographic separation.  For the separation of non-ionic samples, changes in 
selectivity can be achieved by a change in solvent strength (%B), temperature, solvent 
type (such as acetonitrile or methanol as the organic solvent), or the type of stationary 
phase used (such as C18 vs. cyano).  The relative effectiveness for a change in selectivity 
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varies in the following order:  temperature (least effective) < %B < solvent type ≈ column 
type (most effective). 
When considering changing the type of solvent to change selectivity, it is 
important to keep constant the strength of the mobile phase in order to maintain 
comparable values of k and run time.  For example, because methanol is a weaker B-
solvent than acetonitrile, using the solvent nomograph in Figure 1.10, we can see that 
46% of acetonitrile should be about equivalent in strength to 57% methanol [43].   
 
 
 
Figure 1.10 Solvent-strength nomograph for reversed-phase HPLC.  Two mobile phases 
of equal strength (46% ACN and 57% MeOH) marked by ● as an example [13]. 
 
 
 
Changing the type of column frequently provides the most effective way of 
changing selectivity, although often times with complex mixtures, a single column may 
not be able to provide baseline resolution of all peaks, and the real advantage of a change 
in column selectivity is obtained only when a change in column is accompanied by a 
simultaneous change in one or more other conditions, such as the solvent type, %B, 
and/or temperature. 
Besides for the separation of non-ionic (or neutral) compounds, RPLC is also a 
very commonly used technique for the separation of relatively small (<1,000 Da) ionic 
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(acids and bases) compounds.  When an acid (HA) such as carboxylic acid, or base (B) 
such as an aliphatic amine, undergoes ionization (changes from an uncharged to a 
charged species), it becomes much more polar or hydrophilic resulting in a reduced 
retention factor k, sometimes up to 10-fold less.  Therefore, the retention of ionic 
compounds in RPLC is highly dependent on the mobile phase pH [44].  A hypothetical 
illustration of the RPLC separation of an acid (carboxylic acid) and a base (aliphatic 
amine) is shown in Figure 1.11.  
 
 
 
Figure 1.11 Hypothetical illustration of the RPLC separation of an acidic compound HA 
from a basic compound B as a function of pH.  Sample separation as a function of 
mobile-phase pH (t0 = 1.0 min) [13]. 
 
 
 
Table 1.1 provides a list of commonly used buffers in RPLC, including buffer pKa 
values and the mobile phase pH range in which the buffer is effective.   
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Table 1.1 List of commonly used buffers in RPLC [13]. 
 
 
 
 
 
1.4.3 Ion-exchange liquid chromatography 
 
Ion-exchange (IEX) chromatography is another type of liquid chromatography 
that is especially popular for the separation of biomolecules, such as amino acids, 
peptides, proteins, and oligonucleotides.  In IEX, the separation is based on the 
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differential electrostatic affinities of charged molecules for an oppositely-charged 
stationary phase or solid support.  Depending on the charges present on the stationary 
phase and on the molecules that will be adsorbed to it, there are two types of IEX 
chromatography. 
In cation exchange chromatography, the stationary phase carries a negative 
charge, such as –SO3
-
 (a strong cation-exchanger) or –CO2
-
 (a weak cation-exchanger), 
and will have affinity for molecules in solution that carry a net positive charge.  In 
contrast, in anion exchange chromatography, the stationary phase carries a positive 
charge, such as a quaternary amine (a strong anion-exchanger) or a tertiary amine (a 
weak anion-exchanger), and will have affinity for molecules in solution that carry a net 
negative charge [45]. 
Analyte retention and selectivity in IEX is strongly dependent on the pH and ionic 
strength of the mobile phase.  A molecule containing one or more ionizable groups will 
be charged (positive or negative) over a given pH range.  For example, if the pH of the 
mobile phase is well above a weak acid’s pKa, then the analyte will be charged and will 
interact with the charges on the stationary phase.  If the pH of the mobile phase is 
lowered significantly below the pKa value, the acidic analyte will no longer be charged 
and it would no longer have affinity for the ion exchange resin.  This is the principle in 
the use of a pH gradient for the elution of molecules from an ion-exchange column, 
where the molecule is adsorbed to the column at a pH that gives it a charge that is 
opposite of the charge on the resin, and it is eluted by a change in pH that causes it to lose 
its charge and affinity for the resin. 
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Ionic strength (salt) gradients are most often used for the elution of molecules 
from ion-exchange columns.  As the concentration of the counter-ions in the mobile 
phase increases, they begin to compete electrostatically with adsorbed molecules bound 
to the charged resin.  For example, as the concentration of positively charged ions in the 
mobile phase increases by purposely increasing the concentration of a salt in the mobile 
phase such as NaCl, the positively charged Na
+ 
ions will compete with the positively 
charged molecules for binding to a cation exchange resin.  The type of counter-ion in the 
mobile phase also has an effect on the solvent strength and overall sample retention and 
elution.  Generally, counter-ions with a higher charge will be more effective at reducing 
sample retention.  The relative ability of an ion to bind more strongly and provide smaller 
values of retention factor k is in the following order [13]: 
(anion exchange) F
-
 (larger values of k) < OH
-
 < acetate
-
 < Cl
-
 < SCN
-
 < Br
-
 
< NO3
-
 < I
-
 < oxalate 
-2
 < SO4
-2
 < citrate
-3
 (smaller values of k) 
(cation exchange) Li
+
 (larger values of k) < H
+ 
< Na
+
 < NH4
+
 < K
+
 < Rb
+
 
< Cs
+
 < Ag
+
 < Mg
+2
 < Zn
+2
 < Co
+2
 < Cu
+2
 < Cd
+2
 < Ni
+2
 < Ca
+2
 < Pb
+2
 
< Ba
+2
 (smaller values of k) 
 
1.4.4 Ion-pair reversed-phase liquid chromatography 
Ion-pair reversed-phase liquid chromatography (IP-RPLC) is also used for the 
separation of ionic compounds, where suitable counter-ions (such as sulfonic acids, 
sulfonates, and sulfates for bases and quaternary ammonium compounds for acids) are 
38 
 
used in the mobile-phase.  In general, a neutral ion-pair is formed from a water soluble 
cation and a water soluble anion, which then interacts with the stationary phase [46-48]. 
Different mechanisms regarding the ion pair retention have been proposed, 
depending whether the ion-pair process occurs in the mobile phase [49] or in the 
stationary phase [50].  In the first proposed mechanism, ion-pair formation occurs in the 
aqueous mobile phase, and the neutralized ion-pair is then adsorbed onto the hydrophobic 
stationary phase.  Retention is primarily controlled by the length of the carbon-chain on 
the ion-pairing reagent; the greater the non-polarity of the ion-pair (i.e., the 
hydrophobicity of the ion-pairing reagent and the analyte ion), the greater the retention.  
In the second mechanism, the unpaired ion-pairing reagent (such as alkylammonium ion) 
from the mobile phase is adsorbed onto the stationary phase, which then acts as an ion 
exchanger along the surface of the stationary phase and allows the separation of charged 
analytes.  Retention is controlled in a similar way to traditional ion exchange 
chromatography that has just been discussed, where the retention increases in proportion 
to the number of charges and the length of the alkyl chain in the ion-pairing reagent, and 
the proportion of the organic solvent in the mobile phase, where retention is decreased 
with higher concentration of the organic solvent such as acetonitrile. 
 
1.4.5 Size exclusion chromatography 
In size-exclusion chromatography (SEC), samples are separated based on their 
hydrodynamic size where the largest molecules tend to elute first and smallest molecules 
tend to elute last, as a result of the exclusion of larger molecules from smaller pores in the 
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column packing [51, 52].  This technique, when applied to synthetic polymers with 
mobile phases using organic solvents and polymeric stationary phases, is referred to as 
gel permeation chromatography (GPC).  On the other hand, when separating biopolymers 
(such as proteins) using aqueous buffers as mobile phases and hydrophilic stationary 
phases, this technique is referred to as gel filtration chromatography (GFC).  GFC can be 
used as either an analytical tool to obtain information about analyte molecular size or 
shape and aggregation state, or as a preparative tool to isolate biologically active 
compounds. 
The retention in SEC depends only on the relative permeation of solute molecules 
into and out of the pores of the stationary phase.  The molecules that are too large to enter 
any of the pores elute in a volume equal to the interstitial volume (volume between the 
stationary phase particles, V0).  The molecules that are small enough to freely enter the 
pores elute in a volume equal to the sum of the interstitial volume (V0) plus the volume of 
the pore system (Vi).  Any intermediate molecules can enter some portion of the pores 
and therefore elute between V0 and V0 + Vi, depending on their size and shape.  The 
extent to which a solute can penetrate the pore system is determined by its distribution 
coefficient KD [13]: 
   
     
  
     (1.38) 
where VR  is the solute elution volume.  From this expression it can be seen that 
molecules that are too large to enter the pores will have KD = 0 and molecules small 
enough to freely penetrate the entire pore system will have KD = 1; molecules of 
intermediate sizes will have KD values between 0 and 1. 
40 
 
The relationship between molecular size and retention volume can be used to 
determine the molecular weight (MW) of an analyte (Figure 1.12).  A calibration curve of 
log MW vs. retention volume (or KD) will exhibit a linear correlation between V0 and Vi, 
or KD values between about 0.2 and 0.8 (referred to as the separation range).  It is also 
important to note that the retention is actually determined by the hydrodynamic diameter 
of the solute, which is indirectly related to the MW.  The hydrodynamic diameter of a 
protein can vary with solute hydration and molecular shape, where two proteins with 
similar MW but different shapes (e.g., spherical vs. rod-like, or native vs. denatured) will 
have different hydrodynamic diameters.  In order to obtain more accurate MW estimates, 
it is important that proteins used to construct the calibration curve have similar shapes as 
the analytes. 
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Figure 1.12 Hypothetical SEC calibration curve (a) and chromatogram (b) [13]. 
 
 
 
There are mainly two types of stationary phases used in GFC:  hydrophilic 
bonded silicas and hydrophilic organic polymers.  Silica (derivatized to prevent 
interaction with proteins) is widely used in GFC because of its mechanical stability and 
availability in a range of pore sizes.  Hydrophilic organic polymers, such as 
polymethacrylate supports which are more stable under high pH conditions, are also used 
but are less efficient.  The mobile phase is selected such that it maintains the solute in 
solution and in the appropriate conformation (e.g., native vs. denatured) and minimizes 
column-solute interactions.  A typical mobile phase consists of 100 mM potassium 
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phosphate and 100 mM potassium chloride (pH 6.8), with small amounts of organic 
solvents, such as methanol or ethanol, to reduce hydrophobic interactions. 
 
1.4.6 Affinity chromatography 
 
Affinity chromatography is based on specific “lock-and-key” interactions between 
the analytes and ligands on the stationary phase.  It is a unique purification technique 
because it is the only separation mode that provides purification of a biomolecule on the 
basis of its biological function and overall chemical structure.  Purifications that can be 
very difficult and even impossible with most analytical techniques can be easily achieved 
with affinity chromatography.  Retention depends on the secondary structures of 
biological macromolecules, making this type of chromatography highly specific and most 
powerful for separation of biomolecules [53, 54]. 
Biological interactions between ligand and target molecule can be a result of 
electrostatic interactions, hydrophobic interactions, and/or hydrogen bonding.  To elute 
the target molecule from the affinity stationary phase, the interaction of ligand and target 
molecule can be reversed, either specifically using a competitive ligand, or non-
specifically by changing the pH, ionic strength and polarity.  Successful affinity 
purification requires a biospecific ligand that can be covalently attached to the 
chromatographic media, which retains its specific binding affinity for the target 
molecules, and the binding is reversible to allow the elution of the purified target 
molecules.  Some typical biological interactions used in affinity chromatography are the 
following [55]: 
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• Enzyme - substrate analogue and/or inhibitor. 
• Antibody - antigen, virus, cell. 
• Nucleic acid - complementary base sequence, histones, nucleic acid polymerase, 
nucleic acid binding protein.  
• Hormone, vitamin - receptor, carrier protein. 
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Figure 1.13 Typical affinity chromatography purification [55]. 
 
 
 
Typical affinity chromatography purification is illustrated in Figure 1.13.  First, 
the column is prepacked with ligand molecules that can bind reversibly to a specific 
target molecule (or to a specific group of target molecules).  Then, buffer conditions are 
optimized so that target molecules effectively interact with the stationary phase and bind, 
washing all other molecules away.  Next, the buffer conditions are changed to reverse or 
weaken the interaction of the target molecule with the ligand to be able to elute the target 
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compound from the column.  Finally, the column is washed and re-equilibrated with 
buffer to starting conditions and ready for the next cycle. 
Most of the LC techniques described above, such as RPLC, IP-RPLC, IEX, and 
affinity chromatography, were studied for analysis and separation of short RNA (~20-
mer) oligonucleotide samples, and the research results are presented in the following 
chapters. 
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Chapter 2: Introduction to Short RNA Oligonucleotides and their Analysis and 
Separation by Liquid Chromatography 
 
2.1 Introduction 
There has been a considerable recent interest in synthetic oligonucleotides as a 
result of new developments in the use of antisense and small interfering RNA (siRNA) as 
potential therapies [1-3].  Antisense oligonucleotides are single-stranded RNA molecules 
that target and bind with a specific messenger RNA (mRNA) and prevent the translation 
or suppress the expression of a protein encoded by the mRNA.  They are referred to as 
antisense (or guide strand) because they complementary bind to the sense sequence, 
which is part of the mRNA and translates itself into a protein, whereas antisense is the 
complementary strand that hybridizes with the mRNA and prevents it from carrying out 
its function.  In theory, antisense molecules can be applied to any disease in which 
protein overexpression is detrimental, and they are now being evaluated as therapies to 
treat a variety of different diseases [4]. 
Small interfering RNAs (siRNA) are double-stranded RNA molecules of about 21 
base pair length which achieve a similar end by activating the RNA silencing pathway in 
the ribonucleic acid interference (RNAi) mechanism for regulation of gene expression [5, 
6].  The RNAi pathway is illustrated in Figure 2.1.  The mechanism starts with long 
double-stranded RNA (dsRNA) which gets cleaved by the protein Dicer into smaller 21-
23 nucleotide strands.  These siRNAs are then incorporated into the RNA induced 
silencing complex (RISC), where RISC binds to the guide strand.  The passenger strand 
is then unwound, cleaved and released leaving the guide strand bound to the RISC 
complex.  The guide strand base-pairs with a complementary sequence of the messenger 
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RNA molecule and induces cleavage of the mRNA, thereby preventing protein 
translation.   
 
 
 
Figure 2.1 RNA interference mechanism.  Long dsRNA in the cytoplasm are cleaved into 
21-mer strands (siRNA) by the protein, Dicer.  siRNA is incorporated into RISC 
complex, where the passenger strand is unwound and degraded leaving the guide strand 
bound to RISC.  The guide strand base-pairs with a complementary sequence of the 
mRNA and induces cleavage of the mRNA, thereby preventing protein translation.  
Synthetic siRNAs can be introduced into the cell and achieve the same action in the 
RNAi mechanism [71]. 
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2.2 Historical perspective 
The RNAi phenomenon was first discovered in C. elegans by injecting dsRNA 
which led to an efficient sequence-specific gene silencing and the term “RNA 
Interference” was introduced [7]. Working with C. elegans, Fire and Mello showed that 
the gene silencing effect was triggered by a double-stranded RNA and not a single-
stranded RNA (ssRNA).  Hamilton and Baulcombe, as part of a study of post-
transcriptional gene silencing in plants, further discovered that dsRNA with 21-23 
nucleotide length, or known as small interfering RNAs (siRNAs) were key in the gene 
silencing process in the RNAi pathway [8].  Shortly after, Tuschl et al. showed that 
synthetic siRNAs were able to induce RNAi in mammalian cells [9].  In 2003, Song et al. 
first reported that siRNAs can be used therapeutically in animals [10].  In 2004, Morris et 
al. first observed that siRNA could be used for gene silencing in human cells [11].  Jiang 
and Milner also showed that siRNA could inhibit viral infections in human cells [12].  In 
2006, Drs. Andrew Fire from Stanford University School of Medicine and Craig Mello 
from University of Massachusetts Medical School won the Nobel Prize in medicine or 
physiology for their work on RNA interference [13]. 
This significant discovery and the use of siRNA for gene silencing in animals and 
human cells led to a surge of interest in using siRNA for biomedical and drug 
development research. Many biomedical and pharmaceutical companies started to 
explore the use of siRNA as therapies for the treatment of different diseases such as 
cancer, macular degeneration and viral infections [14].  During the late 1990s, ISIS 
Pharmaceuticals Inc. and other biomedical companies initiated a number of clinical trials 
with different antisense molecules [1, 15].  In 2005, Acuity Pharmaceutical was the first 
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to enter Phase I clinical trials with an antisense drug for age-related macular degeneration 
[16].  In 2006, Alnylam Pharmaceuticals reported first data showing siRNA drug delivery 
in non-human primates [17]. 
Currently, there are three different antisense (single-stranded RNA) drugs that 
have been approved by the U.S. Food and Drug Administration (FDA).   In August 1998, 
Isis Pharmaceuticals Inc. and Ciba Vision received approval by the FDA for Vitravene 
used for the treatment of cytomegalovirus retinitis in patients with acquired 
immunodeficiency syndrome (AIDS) [18].  In December 2004, Eyetech Pharmaceuticals 
Inc. and Pfizer Inc. received FDA approval for Macugen (a pegylated single strand RNA 
aptamer) for the treatment of neovascular wet age-related macular degeneration [19].  
More recently, in January 2013, Genzyme and ISIS Pharmaceuticals Inc. received FDA 
approval for Kynamro (an antisense therapeutic) to treat people who are genetically 
predisposed to have high levels of low density lipoprotein (LDL) cholesterol [20]. 
However, due to the enormous challenges for introducing the siRNA into the 
cells, there are currently no approved siRNA drugs on the market.  Delivery of the 
siRNAs into the cells is the biggest challenge of siRNA drug development.  Lipid and 
polymer-based systems are the most studied approaches for siRNA delivery, with lipid 
nanoparticles (LNP) being the most advanced [1]. 
 
2.3 Oligonucleotide and siRNA structure and preparation 
Ribonucleic acid is a biologically important molecule that consists of a long chain 
of nucleotide units. Each nucleotide contains a ribose sugar, a nitrogenous base, and a 
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phosphate group.  There are four bases in RNA:  adenine (A), guanine (G), cytosine (C), 
and uracil (U).  Oligonucleotides are short, single-stranded RNA or deoxyribonucleic 
acid (DNA) molecules with up to about 50 nucleotide unit length (Figure 2.2). 
Oligonucleotides can readily bind, in a sequence-specific manner, to their 
respective complementary oligonucleotides to form duplexes. The binding occurs based 
on Watson-Crick base pairing, where two nucleotides can form hydrogen bonds and are 
referred to as a base pair (bp).  In RNA, adenine and uracil base pair and form two 
intermolecular hydrogen bonds, and guanine and cytosine form three hydrogen bonds 
(Figure 2.3).  Double-stranded RNA (dsRNA) with high G-C content tends to be more 
stable.  Overall, dsRNA are relatively stable at room temperature but the two strands can 
separate, or ‘melt’, at higher temperatures.  The melting point is dependent on the length 
of the molecules, the extent of any mispairing, and the amount of G-C content. 
 
 
  
55 
 
 
Figure 2.2 Oligonucleotide structure. Each nucleotide unit contains a ribose sure, a 
nitrogenous base on the 1’-position, and phosphate groups on the 3’- and 5’-positions, 
forming the phosphodiester backbone.  The four bases in RNA are:  Adenine (A), 
Guanine (G), Cytosine (C), and Uracil (U) [71]. 
 
 
 
 
Figure 2.3 Watson-Crick base pairing in RNA.  Guanine base pairs with cytosine by 
forming three intermolecular hydrogen bonds (G-C), and adenine base pairs with uracil 
by forming two intermolecular hydrogen bonds (A-U). 
 
 
 
Uracil
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Small-interfering RNA (siRNA) is a small double-stranded RNA (usually 21 
nucleotides) with two nucleotide overhangs on each 3’-end.  Each strand has a 5’-
phosphate group and a 3’-hydroxyl group (Figure 2.4). 
 
 
 
Figure 2.4 siRNA structure.  A 21-mer siRNA is shown with two nucleotide overhangs 
on each 3’-end.  Each strand has a 5’-phosphate group and a 3’-hydroxyl group.  The 
siRNA duplex consists of two complementary strands, the sense (or passenger) and 
antisense (or guide) strands [71].  
 
 
 
Various chemical modifications are often made to synthetic oligonucleotides to 
prevent attack by endogenous nuclease enzymes, which can lead to siRNA degradation 
and instability [21, 22]. Incorporation of either a fluoro or methoxy group into the 2’ 
position of the sugar or the use of a phosphothioate linkage is commonly used to improve 
siRNA stability (Figure 2.5) [23].  In the phosphorothioate modification, one oxygen 
atom in the phosphodiester linkage is replaced with a sulfur atom.  This introduces an 
additional stereocenter into the molecule giving rise to 2 possible diastereomers for every 
phosphothioate linkage, and making the resulting oligonucleotide sample mixtures highly 
complex and very difficult to chromatographically resolve.  All of these modifications 
help to improve oligonucleotide stability while retaining, and sometimes even increasing, 
their silencing activity.  These modifications also tend to increase the hydrophobicity of 
3’-OH
3’-OH 
5’-PO4
5’-PO4
siRNA Structure
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the oligonucleotides, while also increasing the temperature at which the duplex melts 
(Tm) into its corresponding single strands. 
 
 
 
Figure 2.5 Structures of various oligonucleotide modifications.  Different modifications 
include:  phosphorothioate backbone modification where one oxygen atom on the 
phosphodiester backbone is replaced with a sulfur atom, and 2’-sugar modifications, such 
as 2’-F and 2’-O-Me [71]. 
 
 
 
Oligonucleotides are readily prepared synthetically via stepwise synthesis using 
phosphoramidite chemistry with automated solid phase synthesizers [24].  Several 
different instruments were developed for this purpose, with the BioAutomation MerMade 
series being one of the mainly used instruments [25].  The synthetic process starts with 
condensation of a protected 5’-dimethoxytrityl-2’-deoxynucleoside-3’-phosphoramidite 
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to a base-protected 2’-deoxynucleoside attached to a controlled pore glass support, 
typically using tetrazole as an activator.  In the next step of the cycle, acetic anhydride in 
pyridine is used to acylate any unreactive nucleoside and to remove phosphite adducts 
from the bases.  This step is followed by oxidation using iodine in aqueous lutidine, 
which converts the phosphite internucleotide linkage to phosphate.  Following removal of 
the dimethoxytrityl group, the cycle is complete and the resulting dinucleotide is ready 
for addition of the next nucleotide.  This cycle is repeated until the desired length 
oligonucleotide product is synthesized (Figure 2.6).  Finally, the final oligonucleotide 
product is removed from the support and the protecting groups are eliminated using a 
mild base such as ammonia.  The crude product can then be purified by different liquid 
chromatography approaches, such as strong-anion exchange liquid chromatography 
(SAX-LC) or reversed-phase high-performance liquid chromatography (RP-HPLC).  
Double stranded siRNAs are prepared by hybridization or annealing of two 
complementary single-stranded RNA counterparts. 
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Figure 2.6 The synthesis cycle of preparing oligonucleotides using phosphoramidite 
chemistry on controlled pore glass supports [25]. 
 
 
 
Although the synthetic process can be very efficient and with good yields, the 
final oligonucleotide product typically contains a variety of closely related impurities, 
that can be very difficult to separate and remove during final product purification [26].  
Some of the most common impurities include sequence deletions, such as n-1, n-2, etc., 
where one or more nucleotide fails to attach to the sequence during synthesis. 
Additionally, depurination, oxidation, and other chemical modification or 
degradation of the nucleotide bases can lead to a variety of closely related impurities that 
can be very challenging to separate.  When dealing with double-stranded siRNAs, the 
sample mixtures can become even more complex with each strand introducing its own set 
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of impurities.  These impurities include mismatched sequences and noncomplementary 
single stranded sequences.  The presence of these impurities in a therapeutic mixture can 
lead to unwanted and detrimental nontargeted gene silencing.  The presence of any 
nonhybridized single-stranded RNAs can also lead to a decrease in therapeutic potency.  
Therefore, when developing siRNA therapeutics, one of the major challenges is 
assurance of good purity to minimize off-target gene silencing effects.  Consequently, 
developing good chromatographic techniques is very critical in the oligonucleotide drug 
development process. 
 
2.4 Chromatographic separations 
The development of analytical methods for sensitive and quantitative analysis of 
therapeutic oligonucleotides is an essential part in the advancement of this research area.  
The analytical methods must be able to separate all impurities from these very complex 
mixtures to ensure good product purity and minimize off-target gene silencing.  When 
developing analytical methods for the separation of oligonucleotides, some of the unique 
oligonucleotide features need to be considered.  First, the pKa of the phosphodiester 
linkage is 2 and in aqueous solution above pH 4 they exist as polyanionic (negatively 
charged) species, that is, for a 21-mer oligonucleotide there will be 21 negative charges at 
pH 7.  Therefore, traditional RPLC conditions tend not work so well for the retention and 
separation of oligonucleotides, and ion-pair RPLC or anion-exchange chromatography 
techniques need to be considered.  Secondly, the single stranded RNA oligonucleotides 
are likely to form higher order (tertiary) structures, and elevated chromatographic 
temperatures need to be used for their efficient analysis [27].   
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Also, when analyzing sinlgle-strands vs. duplex samples, different methods need 
to be considered, such as high temperature (typically >60 °C) for analysis of single 
strands, and low temperature (<25 °C) for analysis of duplex samples to prevent on-
column melting.  A typical siRNA duplex LC analysis is shown in Figure 2.7.  Overlaid 
chromatograms of the corresponding guide and passenger strands are also shown.  This 
method is typically used for the duplex analysis and to report any residual single strands.  
Finally, since RNA and DNA molecules both have a strong absorbance at 260 nm, these 
samples are often analyzed using ultraviolet (UV) detection, although fluorescence and 
especially MS detection [28] are also quite important for RNA analysis. 
 
 
 
Figure 2.7 Typical duplex 21-mer siRNA analysis by UHPLC method.  Overlaid 
chromatograms for the corresponding guide and passenger strands are also shown.  
Column:  Waters CSH C18 (100 mm x 2.1 mm, 1.7 µm particle size).  Chromatographic 
conditions:  mobile phase A = 400 mM HFIP/16.3 mM TEA in water (pH 7.9), mobile 
phase B = methanol.  A segmented linear gradient was used:  25-33%B in 10 min, 33-
36%B in 20 min, 36-60%B in 28 min, 3 min post equilibration at 25%B, total run time 31 
min.  Flow rate:  0.3 mL/min, UV detection at 260 nm, and column temperature set at 15 
°C. 
 
 
 
There have been a number of chromatographic methods reported for the analysis 
and purification of oligonucleotides, including capillary gel electrophoresis (CGE) [29, 
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30], anion-exchange high-performance liquid chromatography (AEX-HPLC) [31-44], 
ion-pair reversed-phase liquid chromatography (IP-RPLC) [45-63], and mixed-mode 
liquid chromatography [65-68].  The different liquid chromatography techniques are 
reviewed in the following sections. 
 
2.4.1 Ion-exchange liquid chromatography 
Ion-exchange chromatography is an excellent method for separating charged 
molecules, and it is a commonly used chromatographic method for the separation of 
multiply charged oligonucleotides [31].  In ion-exchange chromatography, the separation 
is based on the differential electrostatic affinities of molecules carrying a charge for a 
charged stationary phase or solid support.  For the separation of oligonucleotides, which 
are highly negatively charged molecules, anion-exchange chromatography is used with 
positively charged stationary phases that exchange the negatively charged 
oligonucleotides through competition with anions from the mobile phase.  As a result, 
longer oligonucleotides with greater charge are more strongly retained on the column, 
and shorter oligonucleotides have progressively fewer negative charges and have 
progressively shorter retention.  As such, this method is especially useful for the 
separation of the very common N-x deletions of oligonucleotides (Figure 4.1a), and not 
as useful for detecting more subtle changes on the full-length sequence (Figure 4.1b). 
Successful separation of small oligonucleotides and their sequential analysis by 
anion-exchange HPLC were originally reported [32, 33].  In these studies, anion-
exchange (AEX) columns, such as Permaphase AEX (DuPont) or Partisil SAX 
(HiChrom), with salt gradient using phosphate or acetate buffers were used.  Later, 
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Pingoud et al. showed the use of SAX-LC for the excellent resolution of longer 
oligonucleotides, up to 64 chain length, using Whatman SAX column and phosphate salt 
gradient [34].   
The types of anion-exchange resins were continuously modified to improve the 
resolution of oligonucleotides with SAX-LC.  Alkylamine derivatized [35] and 
polyethyleneimine (PEI) coated [36, 37] porous silica phases were prepared for the AEX-
HPLC separation of oligonucleotides, where resolution of oligonucleotides up to 30 bases 
was obtained.  Further optimization of the PEI bonding chemistry with quaternization of 
the ion-exchange matrix showed to increase the resolution of oligonucleotides from 30 to 
50 bases [38].  The relative chemical instability of the silica-based stationary phases, 
however, can be a significant disadvantage.  Consequently, PEI coated porous zirconia 
stationary phases were prepared for use as anion exchangers in SAX-LC of 
oligonucleotides [39].  These new stationary phases were able to provide separation of up 
to 50 nucleotide length with single nucleotide unit resolution.  Furthermore, direct 
comparison of the zirconia-based stationary phases at elevated column temperatures of 75 
°C, which is advantageous and allows for the elution of oligonucleotides under low ionic 
strength mobile phase, with silica-based anion exchanger showed excellent separation of 
oligonucleotides with the zirconia-based columns, whereas silica-based column lost all 
retention toward anions. 
The development of non-porous anion exchangers for use in SAX-LC of proteins 
[40] and oligonucleotides [41] is another important milestone.  These non-porous 
columns, such as TSKgel, were prepared by introducing diethylaminoethyl (DEAE) 
groups into non-porous spherical hydrophilic resins with 2.5 µm in diameter [41].  The 
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effects of some of the critical chromatographic parameters in SAX-LC for 
oligonucleotides were also studied.  Examination of the eluent pH showed that pH should 
be ≥8.5 for the separation of oligonucleotides.  Furthermore, the range pH 8.5-9.5 was 
better suited for the separation based on chain length, while pH 10.5 was better suited for 
the separation based on base composition.  Since these stationary phases are chemically 
very stable, operating at high pH would not cause any problems.  The effect of the type of 
salt was also examined, where sodium chloride and sodium perchlorate were compared, 
and in general the type of salt showed small effect on the separation, provided that the 
gradient steepness was properly adjusted.  Other useful methacrylate-based (polymeric) 
anion-exchange stationary phases have also been developed and successfully used for 
oligonucleotide separations [42-44]. 
 
2.4.2 Ion-pair reversed-phase liquid chromatography 
Ion-pair reversed-phase LC is another very commonly used LC technique for the 
analysis and separation of oligonucleotides [45-47].  The IP-RPLC separation is 
described in section 1.4.4.   
In IP-RPLC, in addition to the charge-charge interactions, hydrophobic 
interactions from the individual bases also significantly contribute to the overall 
oligonucleotide retention.  The hydrophobicity of oligonucleotide bases follows the order 
C < G < A < T (for DNA bases), with cytosine being the least hydrophobic base [48, 49].  
Therefore, in addition to the oligonucleotide length, the retention of oligonucleotides also 
depends on the specific base composition where the overall hydrophobicity is the sum of 
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all the bases in the sequence.  As such, IP-RPLC can be especially useful for separating 
impurities from changes in the full-length sequence, such as depurinations and other 
chemical modifications on the bases.  An example of a separation of an oligonucleotide 
and a series of its deletions (N-1 to N-15) are shown in Chapter 4 (see Figure 4.2a).  This 
illustrates the retention of oligonucleotides by IP-RPLC where the longer 
oligonucleotides are more retained, but overall retention is mostly governed by the base 
composition, where cytosine (least hydrophobic) base deletions resulted in increased 
retention.  Additionally, the IP-RPLC method provided some separation of very small 
differences on the oligonucleotide sequence, such as the reversal of two neighboring 
bases at different locations along the sequence (Figure 4.2b). 
Triethylammonium acetate (TEAA) is one of the most commonly used ion-pair 
reagents for the separation of oligonucleotides because of its good separation efficiency 
[50, 51].  Typical TEAA concentrations are 100 mM at pH 7 with acetonitrile as the 
organic solvent.  Gilar et al. did an extensive study for retention prediction of 
oligonucleotides with IP-RPLC using TEAA at pH 7 as ion-pairing reagent [52].  Using 
39 different oligonucleotides, they demonstrated the successful application of their model 
for the prediction of the mobile phase strength required to elute the oligonucleotides.  
Furthermore, shallow linear gradients of organic modifiers are typically used because 
studies have shown that there is a sharp change of the retention factor in oligonucleotides 
(or large biopolymers compared to small molecules) with a small change in the mobile 
phase strength.  Gilar et al. reported that the retention factor (k) for 15-mer 
oligonucleotide decreases from 100, 13.5, to 3.2 with a very small change of mobile 
phase composition from 8, 9, to 10% acetonitrile, respectively [52]. 
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Another very useful ion-pairing mobile phase is the combination of 
hexafluoroisopropanol (HFIP) and triethylamine (TEA) buffer system proposed by 
Apffel et al. [53].  This HFIP-based separation uses methanol as the organic modifier, 
because HFIP is immiscible with acetonitrile, and miscible with water, methanol, 
isopropanol and hexane.  Using 400 mM HFIP and adjusting the solution to pH 7.0 with 
TEA, comparable separations were obtained as those with 100 mM TEAA mobile phases.  
The main difference, however, was in the electrospray ionization (ESI) performance for 
the mass spectrometric (MS) detection of oligonucleotides.   
Comparison of different solvent systems, such as 400 mM HFIP adjusted to pH 
7.0 with TEA, water, 100 mM TEAA (pH 7), and 25 mM TEA (pH 10), showed superior 
MS signal with the 400 mM HFIP buffer system, compared to significantly suppressed 
MS signal with the 100 mM TEAA buffer.  This significant difference in MS detection 
was attributed to the dynamic adjustment of the pH in the ESI droplet as a function of the 
removal of the anionic counterion from the droplet by evaporation.   
First, comparing the volatilities for the two different buffer systems, HFIP 
(boiling point bp = 57 °C) is more volatile than TEA (bp = 89 °C), with acetic acid being 
the least volatile (bp = 118 °C).  Secondly, the weak acid/base system with HFIP/TEA 
maintains a stable pH at ~7.0.  The pKa values of acetic acid, HFIP, and TEA are 4.75, 
~9, and 11.01.  Therefore, at pH 7.0, acetic acid is completely dissociated and it cannot 
be removed by evaporation in the MS source, whereas HFIP is not charged and it can be 
evaporated freely. 
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Furthermore, the mechanism proposed by Apffel suggests that during the 
separation, the TEA ions ion-pair with the negatively charged phosphates on the 
oligonucleotide backbone, as the more volatile HFIP is evaporated from the droplet 
surface causing the pH on the surface to rise (~ pH 10).  As the pH rises, the 
oligonucleotide – TEA ion pair dissociates, and the oligonucleotide can be desorbed into 
the gas phase. 
Additionally, the role of TEA is also very important in this mechanism because in 
general oligonucleotides have a high binding affinity for Na
+
 and K
+
 cations on the 
polyanionic phosphate backbone and these cation adducts can diminish the sensitivity for 
electrospray ionization.  The use of a strong base such as TEA effectively suppresses the 
sodium and potassium adducts formation by a displacement mechanism and consequently 
dramatically increases the electrospray ionization sensitivity.  This HFIP/TEA mobile 
phase system is now routinely used for oligonucleotide analysis with IP-RPLC and ESI-
MS detection [53-60]. 
Gilar et al. further evaluated the HFIP/TEA buffer system and showed that 
concentration of the ion-pairing triethylammonium (TEA) ion, rather than the 
concentration of HFIP, in the mobile phase plays a critical role in the separation [57].  
They extensively studied the effect of the concentration of both, TEA and HFIP in the 
mobile phase by varying the TEA concentration from 0.56 to 31.4 mM range (pH 7-9), 
and the HFIP concentration from 12.5 to 400 mM, using oligonucleotides up to 30-mer 
length.  They showed that the HFIP/TEA buffer system was most effective at 400 mM 
HFIP and 16.3 mM TEA concentration (where 16.3 mM TEA was the highest 
concentration possible to dissolve in 400 mM HFIP at room temperature).  Interestingly, 
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they also showed that HFIP effectively disrupts any oligonucleotide secondary structures 
and this buffer can be an efficient denaturant that allows for more efficient 
oligonucleotide separations. 
The chromatographic separation of oligonucleotides with IP-RPLC method is 
usually performed with a C18 column, although other reversed phase media can also be 
used.  The mass transfer of relatively larger molecules such as oligonucleotides is one of 
the major factors contributing to peak broadening on porous C18 stationary phases.  A 
study using 50 x 4.6 mm columns packed with 5, 3.5 and 2.5 µm particle size columns 
showed that the mass transfer in the stationary phase had a major impact on the 
separation (Figure 2.8) [52]. In order to overcome this problem, smaller particle size 
columns (≤ 2.5 µm diameter particle size) using ultra-high performance LC (UHPLC) 
instruments can be used to improve the overall separation performance [50]. 
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Figure 2.8 Impact of sorbent particle size on the separation of a 2-30mer 
oligodeoxythymidine ladder.  The separation was performed using a XTerra MS C18 30 
x 4.6 mm column packed with 2.5 µm (A), 3.5 µM (B), and 5 µm sorbent (C) [52]. 
 
 
 
Additionally, Kirkland et al. have previously shown the advantage of core-shell 
C18 particle columns for fast HPLC analysis of macromolecules such as proteins and 
nucleic acids, attributing this improved performance to superior mass transfer with the 
core-shell particles [61, 62].  We performed a systematic evaluation of different core-
shell columns for improved analysis and separation of oligonucleotides, and the results 
are presented in Chapter 3 [63]. 
 
2.4.2.1 Purification of siRNAs by IP-RPLC 
McCarthy et al. have more recently demonstrated the use of IP-RPLC for the 
analysis and purification of siRNA [50].  Their studies were conducted using an UHPLC 
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instrument.  Small scale purification of single strand RNA was performed using an 
analytical size column and TEAA mobile phase.  As the column was overloaded, typical 
peak broadening was observed with some retention shift of impurities eluting before the 
main peak.  "Heart-cutting" strategy in the preparative separation was used (or main peak 
was collected from its apex to about 30% of the peak height) to obtain good purity of the 
target oligonucleotide without much loss in product recovery.  In this case, 1-2 mL single 
fractions were collected with about 50-70% recovery and >95% purity (Figure 2.9). 
 
 
Figure 2.9 IP-RPLC chromatographic purification of a crude synthetic RNA.  The 
column loading was varied from 1.4 to 140 nmol load.  Fractions were collected for each 
purification from the peak apex to 30% of the peak height.  The eluent was monitored at 
260 nm.  Column:  XBridge OST BEH C18, 4.6 x 50 mm, 2.5 µm.  Mobile phase A:  100 
mM TEAA (pH 7.0); mobile phase B: 20% Acetonitrile in mobile phase A.  Gradient:  
from 30%B (6% Acetonitrile) to 52.5%B (10.5% Acetonitrile) in 30 min, 1 mL/min, 
60°C [50]. 
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Besides single-stranded RNA analysis, McCarthy et al. also performed double-
stranded RNA analysis and purification [50].  However, several different points need to 
be considered when analyzing dsRNAs.  The primary concern is the stability of the 
dsRNA under IP-RPLC conditions.  Most dsRNA have melting temperatures in the range 
of 45 and 65 °C.  Therefore some on-column melting of dsRNA can occur during 
analysis and purification, especially at higher column temperatures.  The on-column 
duplex melting is typically observed as a dramatic peak broadening.  If the column 
temperature reaches or exceeds the duplex melting point then the duplex rapidly melts on 
injection and on column and elutes as the two corresponding single strands.  As a result, 
duplex RNA can be analyzed using lower column temperatures and 20 °C was used in 
this research study.  Purification of the duplex then is possible if there is an efficient 
separation of the target duplex from truncated species.  In this study, full length duplex 
RNA was collected by using heart-cutting strategy that provided duplex target material 
with purity greater than 98%. 
In addition, siRNA purification using on-column annealing was also successfully 
demonstrated.  In this approach, the first strand is injected at initial gradient conditions, 
followed by injection of the complementary strand.  The gradient elution conditions are 
immediately started afterward.  The results showed formation of duplex RNA on-column 
that could then be purified similarly as the single strands.  However, the results also 
showed the on-column annealing approach was less efficient where increased amounts of 
non-annealed single strands were also observed (Figure 2.10). 
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Figure 2.10 IP-RPLC purification of siRNA duplex formed on column after injecting two 
complementary synthetic RNA oligonucleotides.  Column:  XBridge OST BEH C18, 4.6 
x 50 mm, 2.5 µm.  Mobile phase A:  100 mM TEAA (pH 7.0); mobile phase B:  20% 
Acetonitrile in mobile phase A.  Gradient:  from 25% B (5% Acetonitrile) to 75%B (12% 
Acetonitrile) in 30 min, 1 mL/min, 20 °C.  The eluent was monitored at 260 nm [50]. 
 
 
 
2.4.3 Mixed-mode liquid chromatography 
 
Due to the separation mechanism differences between the SAX-LC and IP-RPLC, 
these methods are considered as complementary and often both methods need to be 
utilized for complete analysis and separation of oligonucleotides [64]. As a result, mixed-
mode chromatography columns consisting of both reversed-phase and ion-exchange 
properties have been prepared and evaluated for use in oligonucleotide separations [65-
67].  When using mixed-mode columns, oligonucleotides can experience ionic (such as 
SAX-LC) and hydrophobic (such as RPLC) interactions simultaneously.  The dominating 
mode of interaction can be significantly influenced by the type of the mobile phase used.  
We performed an extensive evaluation of more recently introduced mixed-mode C18 
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columns (Scherzo C18) for improved analysis and separation of oligonucleotides, and the 
results are presented in Chapter 4 [68]. 
 
2.4.4 Affinity chromatography 
Affinity chromatography approaches are the least studied analytical techniques 
for the separation of oligonucleotides.  A few reports have shown the use of affinity 
chromatography purification of oligonucleotide binding proteins [69, 70], and there are 
no reports of short RNA oligonucleotide separation and purification by affinity 
chromatography.  We have explored affinity chromatography separation of 
oligonucleotides by preparing RNA-modified stationary phases and these results are 
presented in Chapter 5. 
The goal of the research presented in the following chapters is to provide 
improvement for the current approaches and explore new and novel methods for short 
RNA oligonucleotide analysis and separations.  First, columns with core-shell particles, 
which have been extensively studied and applied for small molecule separations, were 
evaluated for improved separation of oligonucleotides.  Secondly, very few research 
studies have previously shown the advantage of mixed-mode columns for separation of 
oligonucleotides, and new mixed-mode columns, consisting of anion-exchange and 
reversed-phase, were studied for improved separation of oligonucleotides.  Finally, 
affinity chromatography based on RNA-modified columns was considered and explored 
for the affinity separation of oligonucleotides. 
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Chapter 3: Evaluation of Core-Shell Particle Columns for Ion-Pair Reversed-Phase 
Liquid Chromatography Analysis of Oligonucleotides 
 
3.1 Introduction 
Although the core-shell particle idea was introduced more than 40 years ago [1-
3], these columns were not commercially successful until a few years ago.  As the name 
implies, core-shell particles (also known as fused-core or superficially porous) are 
comprised of a solid core surrounded by a porous layer.  One of the major benefits of the 
core-shell particle is its small diffusion path (e.g., 0.5 µm) compared to fully porous 
particles (e.g., 1.5 µm) as illustrated in Figure 3.1.  This reduced intra-particle flow path 
provides superior mass transfer kinetics and also a better performance at higher mobile 
phase velocities, thus providing efficient and fast analysis.  Additionally, the core-shell 
particles produce only about half the back pressure compared to the porous 1.7 µm 
particles, making it possible to use these columns with conventional high-performance 
liquid chromatography (HPLC) instruments [4]. 
 
 
 
Figure 3.1 Ascentis Express core-shell particle vs. fully-porous particle [5].  
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Starting in 2007, there were four new brands of core-shell particles 
commercialized:  Halo (Advanced Materials Technology) or Ascentis Express (Supelco, 
Sigma Aldrich), Poroshell (Agilent), and Kinetex (Phenomenex).  These columns 
immediately attracted a great deal of attention in industrial and academic laboratories, 
and their chromatographic performances were extensively studied.  Gritti and Guichon 
have demonstrated the efficiency advantages of the core-shell columns over sub-3 µm 
fully-porous particle columns [6-15].  In general, with core-shell particles, sources of 
band broadening are reduced compared to fully porous particles, resulting in 
chromatographic separations with better resolution, higher sensitivity, and improved peak 
shapes (Figure 3.2) [16].  Due to the great benefits with the core-shell particle columns, 
such as fast and efficient separations, these columns are now routinely used for typical 
pharmaceutical small molecule separations [17-19]. 
 
 
 
Figure 3.2 Band broadening minimized with core-shell particles compared to fully porous 
particles [16].   
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Kirkland et al. have previously shown the advantages of core-shell particle 
columns for fast HPLC analysis of macromolecules such as proteins and nucleic acids 
[20, 21], attributing this improved performance to superior mass transfer kinetics.  Also, 
Gilar et al. reported the evaluation of IP-RPLC for oligonucleotide analysis, showing that 
mass transfer of the oligonucleotides in the stationary phase was the major factor 
contributing to peak broadening on porous C18 stationary phases [22].  Based upon the 
reported superior mass transfer kinetics of the core-shell particles, we suspected the core-
shell particle columns might provide improved separations of oligonucleotides, and to our 
knowledge, there were no reports of core-shell particle columns for oligonucleotide 
separations.   Therefore, we undertook an evaluation of a number of RNA 
oligonucleotide 21-mers test analytes using different types of core-shell particle columns 
with differing particle and pore sizes to evaluate their use for improved analysis and 
separation of oligonucleotides. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
3.2 Experimental 
3.2.1 Materials and reagents 
Triethylammonium acetate buffer (TEAA, 1M concentration) was purchased from 
Sigma-Aldrich (St. Louis, MO, USA).  Acetonitrile (MeCN, HPLC grade) was purchased 
from Fisher Scientific (Fair Lawn, NJ).  Deionized water was purified using Hydro ultra 
pure water purification system (Garfield, NJ, USA). 
The oligonucleotide sample library included over 60 different 21-mer non-
modified and modified RNA-based sequences synthesized by Merck RNA synthesis 
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group (Merck proprietary compounds).  The modifications on the RNA-strand included 
2'-methoxy and 2'-fluorine modifications on the ribose sugars. 
 
3.2.2 Instrumentation 
All samples were analyzed by ion-pair reversed-phase liquid chromatography (IP-
RPLC) on an Agilent 1100 HPLC (Agilent, Palo Alto, CA, USA) instrument consisting 
of binary pump LC, degasser, autosampler, column oven, and variable wavelength 
detector (VWD).  The HPLC instrument can have a significant impact on analyte band 
broadening when using high efficiency columns [6].  The instrument was modified to 
reduce extra column volume contributions.  The minor modifications included the 
following:  the tubing connections from the different LC components were minimized.  
The two PEEK connector capillaries, 0.17 mm i.d., 100 mm (green tubing) before the 
column, and 0.17 mm i.d., 300 mm (green tubing) after the column were replaced with 
0.12 mm i.d., 100 mm (red tubing) and 0.12 mm i.d., 300 mm (red tubing), respectively.  
A standard 1100 VWD flow cell (Agilent G1314-60086) with 14 µL volume and 10 mm 
path length was replaced with a smaller volume detector cell (Agilent G1314-60083) with 
5 µL volume and 6 mm path length. 
The system was controlled by Atlas Chromatographic System (Thermo Scientific, 
Waltham, MA, USA).  The data was collected using peak width setting of >0.10 min (2.0 
s). 
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3.2.3 Methods 
The chromatographic analysis was performed using ion-pair RPLC conditions.  
The mobile phase consisted of the following:  reservoir A was 100 mM TEAA in water 
(pH 7), and reservoir B was 100 mM TEAA in acetonitrile.  The optimized platform 
method used a segmented linear gradient:  10-20%B over 15 minutes for the separation of 
most analytes, 20-50%B over the next 3 minutes to elute any late eluting impurities, and 
then a column re-equilibration step of 50-10%B over 2 minutes, for a total run time of 20 
minutes.  A UV detection wavelength of 260 nm was employed, along with a column 
temperature of 60 °C.  The flow rate for the 4.6 mm i.d. columns was 1.5 mL/min, 
whereas the flow rate for the 3 mm i.d. column was 0.6 mL/min (to maintain similar 
mobile phase linear velocity).  The injection volumes for the 4.6 mm i.d. and the 3 mm 
i.d. columns were 5 µL and 2 µL, respectively. 
 
3.3 Results and discussion 
3.3.1 Method development 
In order to assess the utility of core-shell particle columns for the separation of 
small oligonucleotides, a group of currently available core-shell columns and a set of 
representative test analytes for study were assembled.  Columns chosen included different 
core-shell C18 stationary phases, such as Ascentis Express C18 (2.7 µm particle size), 
Poroshell EC-C18 (2.7 µm particle size), Kinetex XB-C18 (2.6 µm particle size), and 
Kinetex C18 (2.6 µm particle size and 1.7 µm particle size).  In addition, core-shell 
columns with different column chemistries were also evaluated, such as Ascentis Express 
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Phenyl-Hexyl and Ascentis Express RP-Amide, both with 2.7 µm particle size (Table 
3.1). 
Table 3.1 Summary of the core-shell particle columns studied, as well as the fully-porous 
column that was used a control. 
 
Column Dimensions Particle size  
(µm) 
Average 
Pore size 
(Å) 
Luna C18 (2) 150 x 4.6 mm 3 
Fully-porous 
100 
Kinetex C18 150 x 4.6 mm 
 
2.6 
Solid core 1.9 µm 
Porous layer 0.35 µm 
100 
 
Kinetex XB-C18 150 x 4.6 mm 2.6 
Solid core 1.9 µm 
Porous layer 0.35 µm 
100 
Kinetex C18 100 x 3 mm 1.7 
Solid core 1.25 µm 
Porous layer 0.23 µm 
100 
Poroshell 120EC-C18 
 
150 x 4.6 mm 
 
2.7 
Solid core 1.7 µm 
Porous layer 0.5 µm 
120 
Ascentis  
Express C18 
150 x 4.6 mm 
 
2.7 
Solid core 1.7 µm 
Porous layer 0.5 µm 
90 
 
Ascentis  
Express Phenyl-Hexyl 
150 x 4.6 mm 2.7 
Solid core 1.7 µm 
Porous layer 0.5 µm 
90 
Ascentis  
Express RP-Amide 
150 x 4.6 mm 2.7 
Solid core 1.7 µm 
Porous layer 0.5 µm 
90 
 
 
 
Test analytes consisted of a set of over 60 different crude (unpurified) RNA 21-
mer reaction products coming directly from automated oligonucleotide synthesis.  
Unpurified samples were chosen for study owing to the fact that multiple impurities can 
be observed in these samples, allowing a good comparison of the ability of different 
columns to separate impurities of potential interest.  The RNA oligonucleotides 
investigated in this study included both natural and unnatural nucleotide bases, such as 
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2’-fluoro or 2’-methoxy and phosphorothioate modifications.  The 2'-fluoro and 2'-
methoxy modified bases typically tend to increase retention in reversed phase 
chromatography, relative to the natural nucleotides containing a hydroxyl group at the 2' 
position. 
One common gradient elution method that could be used to compare all stationary 
phases in the study was used.  Clearly, optimization of chromatographic separations often 
involves changes to both stationary and mobile phases, meaning that any single gradient 
elution method may be better suited for some phases and less well suited for others.  
Nevertheless, current analysis methods for RNA oligonucleotides often use standard 
gradient methods with conventional reversed phase columns, and the choice of a standard 
gradient affords a basis (albeit imperfect) for comparing different stationary phases. 
As previously noted, ion-pair reversed-phase HPLC with amine additives is the 
current method of choice for RNA oligonucleotide analysis.  The most common ion-pair 
reagent used for oligonucleotide analysis is triethylammonium acetate (TEAA) at 100 to 
200 mM concentration.  Although, this additive is not MS friendly, this approach works 
very well for oligonucleotide analysis by UV detection, which is typically carried out at a 
detection wavelength of 260 nm.  Therefore, an eluent consisting of 100 mM TEAA in 
water for the aqueous component (mobile phase A) and 100 mM TEAA in acetonitrile as 
the organic modifier (mobile phase B) was chosen for these studies.    
In general, non-modified RNA samples elute at lower organic modifier 
concentrations (~10%) relative to RNA samples containing modified nucleotides, which 
typically elute with 15-20% organic modifier.  A standard segmented gradient was 
employed, consisting of a relatively shallow gradient of 10-20%B over 15 minutes to 
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elute and separate the majority of the analytes, followed with a steep gradient from 20-
50%B over the next 3 minutes to elute any late eluting impurities.  The column 
temperature was 60 °C.  The injection volumes for the 4.6 mm i.d. and the 3 mm i.d. 
columns were 5 µL and 2 µL, respectively.  The flow rate for the 4.6 mm i.d. and the 3 
mm i.d. columns were 1.5 mL/min and 0.6 mL/min, respectively, which resulted in 
approximately the same linear velocity. 
Although reports have shown that the optimal flow rate for the core-shell particle 
columns is about 2 mL/min (or equivalent) [9], the 1.5 mL/min flow rate (or equivalent) 
was used in these studies for two reasons.  First, when using the 150 mm length x 4.6 mm 
i.d. column with 2.6 µm or 2.7 µm particle size and gradient method with mostly aqueous 
mobile phase (80-90%), even at elevated column temperature of 60 °C, at 2 mL/min flow 
rate the back pressure was at about the limit of the instrument (~390 bars).  When using 
the smaller 1.7 µm core-shell particle column (100 mm length x 3.0 mm i.d.) at 0.9 
mL/min flow rate (equivalent to 2 mL/min flow rate for 4.6 mm i.d. column) the back 
pressure was beyond the instrument limitation (>400 bars).  The 1.5 mL/min and 0.6 
mL/min flow rates resulted in back pressures ~305 bars and ~340 bars, respectively.  
Secondly, when dealing with larger molecules such as oligonucleotides, Gilar et al. have 
shown that the flow rate has a significant impact on the oligonucleotide separations.  
They have shown that slower flow rates (0.5-1.5 mL/min compared to 2 mL/min) provide 
improved separations of oligonucleotides [22]. 
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3.3.2 Comparison of core-shell vs. fully-porous particles 
Our preliminary investigations focused on a quick survey to scout for potential 
advantages of core-shell particle columns relative to conventional fully-porous particle 
columns.  The initial evaluation focused on one column of each type from a single 
vendor, where column chemistries were believed to be comparable.  The fully-porous 
particle column used was a Luna C18 (2) (4.6 mm i.d. x 150 mm) packed with 3 µm 
particles.  For the core-shell particle column, a Kinetex C18 (4.6 mm i.d. x 150 mm) 
packed with 2.6 µm particles was employed; each particle consists of a 1.9 µm solid core 
surrounded by a 0.35 µm porous layer.  These columns were compared using the standard 
segmented gradient described above, a flow rate of 1.5 mL/min, column temperature of 
60°C, and an absorbance detection wavelength of 260 nm. 
The results (Figure 3.3) clearly show improved resolution and sharper peaks for 
the core-shell particle column compared to the fully-porous particle column, as evidenced 
by the ability of the core-shell particle column to resolve a trailing impurity from the 
main peak that is poorly resolved with the fully-porous particle column (arrows).  In 
addition, it is also important to note that more peaks eluting before the main component 
were also better resolved on the Kinetex column, where differences in selectivity and 
narrower peak widths generated this result.  A similarly improved ability to resolve 
closely related impurities from the main peak was generally observed for other 
oligonucleotide samples.  As synthetic oligonucleotide samples often contain numerous 
closely related impurities, the ability to successfully resolve such impurity clusters is very 
important. 
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Figure 3.3 Comparison of core-shell vs. fully-porous particles for oligonucleotide 
analysis by IP-RPLC method. 
Peak 1 = Main peak, Peak 2 = impurity eluting after the main peak (arrow) 
Column 1. Kinetex C18 (150 x 4.6 mm, 2.6 µm), core-shell particle 
RT peak 1 = 7.46 min, RT peak 2 = 7.66 min 
Peak 1 Width (base) = 0.10 min, Peak 2 Width (base) = 0.10 min 
Column 2. Luna C18 (2) (150 x 4.6 mm, 3 µm), fully-porous particle 
RT peak 1 = 7.35 min, RT peak 2 = 7.53 min 
Peak 1 Width (base) = 0.17 min, Peak 2 Width (base) = 0.17 min 
[Note:  The retention times and peak width values were collected using Atlas 
Chromatographic System]. 
 
 
 
3.3.3 Systematic evaluation of different core-shell columns for IP-RPLC 
oligonucleotide analysis 
 
Next, a more thorough analysis of a variety of commercially available core-shell 
particle columns with differing column chemistry, particle size and pore size was 
performed (Table 3.1).  The Ascentis Express (or Halo) and Poroshell core-shell particles 
EV 0302531-189P1A (2,1) Pr_siRNA,RY_LC-296.biba_120207_KinC18_Fig1,2,1,1
Acquired Tuesday, February 07, 2012 10:27:53 PM
-10
0
10
20
30
40
50
60
70
80
90
100
Re
sp
on
se
0 2 4 6 8 10 12 14 16 18 20
Retention time
EV 0302531-189P1A Luna C18 3 um (4,1) Pr_siRNA,RY_LC-296.biba_120207_KinC18_Fig1,4,1,1
Acquired Wednesday, February 08, 2012 3:44:23 PM
-10
0
10
20
30
40
50
60
70
80
90
100
Re
spo
nse
0 2 4 6 8 10 12 14 16 18 20
Retention time
 
Luna C18 (2) Column 
Fully-porous particle 
150 x 4.6 mm id, 3 µm 
R ~ 1.1 
Kinetex C18 Column 
Core-shell particle 
150 x 4.6 mm id, 2.6 µm 
R ~ 2.0 
90 
 
have a particle diameter of 2.7 µm (1.7 µm nonporous core surrounded by a 0.5 µm 
porous shell), and Kinetex core-shell particles have a particle diameter of 2.6 µm (1.9 µm 
nonporous core surrounded by a 0.35 µm porous shell).  The average pore diameter 
reported by the vendors varied considerably among these different particles, with the 
Ascentis Express having an average pore diameter of 90 Å, Kinetex 100 Å, and Poroshell 
120 Å.  This variation in pore size, which might be expected to have only a minor 
influence in traditional small molecule separations, could be important for analysis of the 
significantly larger RNA oligonucleotides used in this study (length ~50 Å).  Finally, a 
recently introduced sub-2 µm core-shell particle (Kinetex 1.7 µm particle size with 1.25 
µm nonporous core surrounded by a 0.23 µm porous shell) was included in the study for 
comparison.  This was the only commercially available sub-2 µm core-shell particle 
column available at the time of our studies. 
Our comparison of three different core-shell C18 columns showed similar results 
for the components of a crude RNA oligonucleotide sample, but with slightly increased 
retention on the Poroshell and Kinetex C18 columns and the best peak shape on the 
Kinetex C18 column (Figure 3.4).  This general trend was observed across the library of 
different RNA sample mixtures.  The improved (narrower) peak shape obtained with the 
Kinetex (2.6 µm) column is consistent with the smaller porous layer of this column (0.35 
µm) relative to the other two columns (0.5 µm). 
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Figure 3.4 Comparison of different core-shell C18 columns for oligonucleotide analysis 
by IP-RPLC method.   
Peak 1 = Main peak, Peak 2 = impurity eluting after the main peak 
Column 1. Ascentis Express C18 (150 x 4.6 mm, 2.7 µm) 
RT peak 1 = 5.97 min, RT peak 2 = 6.15 min 
Peak 1 Width (base)= 0.26 min 
Column 2. Poroshell EC-C18 (150 x 4.6 mm, 2.7 µm) 
RT peak 1 = 6.89 min, RT peak 2 = 7.06 min 
Peak 1 Width (base) = 0.18 min 
Column 3. Kinetex XB-C18 (150 x 4.6 mm, 2.6 µm) 
RT peak 1 = 7.00 min, RT peak 2 = 7.19 min 
Peak 1 Width (base) = 0.13 min 
 
 
 
Next,  evaluation of core-shell columns with different column chemistries was 
performed, including C18, phenyl-hexyl and RP-amide, comparing columns from the 
same manufacturer with the same dimensions and particle sizes (150 mm in length, 4.6 
mm i.d., 2.7 µm core-shell particles and 90Å average pore sizes).  The evaluation results 
showed the most retention with the core-shell phenyl-hexyl column and best separation 
with the RP-amide column (Figure 3.5).  The improved retention with the phenyl-hexyl 
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column could be in part due to an ability to participate in additional π-π interactions of 
the oligonucleotide samples.  The improved separation with RP-amide column, on the 
other hand, could be in part due to increased H-bonding between the amide carbonyl and 
oligonucleotide samples.  Based on literature reports, C18 columns are typically used for 
oligonucleotide analysis by ion-pair reversed-phase liquid chromatography [23-26].  
Given the possible improved separation of oligonucleotides with the RP-amide column, 
this column will be considered as one of the column choices for future method 
development studies for siRNA drug development support. 
 
 
 
Figure 3.5 Comparison of different core-shell columns for oligonucleotide analysis by IP-
RPLC method. 
Column 1.  Ascentis Express C18 (150 x 4.6 mm, 2.7 µm) 
RT peak 1 = 5.97 min, RT peak 2 = 6.15 min; Peak 1 Width (base)= 0.26 min 
Column 2.  Ascentis Express Phenyl-Hexyl (150 x 4.6 mm, 2.7 µm) 
RT peak 1 = 7.72 min; Peak 1 Width (base)= 0.20 min (no separation of impurity) 
Column 3.  Ascentis Express RP-Amide (150 x 4.6 mm, 2.7 µm) 
RT peak 1 = 5.13 min, RT peak 2 = 5.43 min 
Peak 1 Width (base)= 0.14 min, Peak 2 Width (base)= 0.18 min 
Resolution= ~1.9 
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3.3.4 Evaluation of sub-2 µm core-shell particles 
Next, an evaluation of the more recently commercialized sub-2 µm core-shell 
particle column, Kinetex C18 (100 mm in length, 3 mm i.d., and 1.7 µm core-shell 
particles consisting of 1.25 µm solid core surrounded by 0.23 µm porous layer), was 
performed.  As our previous results had shown improved separation of oligonucleotide 
samples with core-shell columns, the smaller sub-2 µm column, as expected, showed 
even greater separation efficiency when analyzing these samples.  As a consequence of 
this improved efficiency, this column can provide reduced analysis time without loss in 
separation efficiency (Figure 3.6). 
 
 
 
Figure 3.6 Comparison of 2.6 µm core-shell with smaller 1.7 µm core-shell particles for 
oligonucleotide analysis by IP-RPLC. 
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Figure 3.6 (continued) 
Column 1.  Kinetex C18 (150 x 4.6 mm, 2.6 µm) 
Gradient:  10-20%B in 15 min, 20-50%B in 2 min, 3 min post equilibration at 10%B 
Flow rate:  1.5 mL/min 
RT peak 1 = 7.00 min, RT peak 2 = 7.19 min 
Peak 1 Width (base) = 0.13 min, Peak 2 Width (base) = 0.16 min 
Column 2.  Kinetex C18 (100 x 3 mm, 1.7 µm) 
Gradient:  10-20%B in 10 min, 20-50%B in 2 min, 3 min post equilibration at 10%B 
Flow rate:  0.6 mL/min 
RT peak 1 = 6.38 min, RT peak 2 = 6.50 min 
Peak 1 Width (base) = 0.09 min, Peak 2 Width (base) = 0.09 min 
 
 
 
It should be noted, however, that the difference in column dimensions (where the 
sub-2 µm core-shell column is only available in 100 mm x 3 mm i.d. or smaller) results in 
differences in void times and hence differences in the gradient steepness due to the 
column length differences, and therefore the advantage of reduced analysis time without 
loss in separation efficiency is not fully realized with a standard LC instrument and it can 
be improved with the use of ultra high-pressure LC (UHPLC) instrument.  In addition, as 
Gritti et al. have reported [6], the HPLC instrument can have a significant impact on 
analyte band broadening when using high efficiency columns.  However, with careful 
instrument modifications to minimize the extra column volume contributions, the sub 2-
µm core-shell particle column with optimized gradient can provide the best separation of 
closely related impurities that could not be separated with the regular (2.6 µm particle 
size) core-shell column (Figure 3.7). 
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Figure 3.7 Sub 2-µm core-shell particle column for improved separation of 
oligonucleotides by IP-RPLC. 
Column 1.  Kinetex C18 (150 x 4.6 mm, 2.6 µm) 
Gradient:  10-20%B in 15 min, 20-50%B in 2 min, 3 min post equilibration at 10%B 
Flow rate:  1.5 mL/min 
RT peak 1 = 7.00 min, RT peak 2 = 7.19 min 
Peak 1 Width (base) = 0.13 min, Peak 2 Width (base) = 0.16 min 
Column 2.  Kinetex C18 (100 x 3 mm, 1.7 µm) 
Gradient:  8-20%B in 15 min, 20-50%B in 2 min, 3 min post equilibration at 8%B 
Flow rate:  0.6 mL/min 
RT peak 1 = 9.88 min, RT peak 2 = 10.06 min 
Peak 1 Width (base) = 0.10 min, Peak 2 Width (base) = 0.13 min 
 
 
 
3.3.5 Core-shell column stability with ion-pair RPLC method for oligonucleotide 
analysis 
 
Overall, the core-shell column evaluation studies with ion-pair RPLC method for 
oligonucleotide analysis showed significantly improved separations when compared to 
Kinetex C18 
(100 x 3 mm, 1.7 µm) 
R~1.6 
Kinetex C18 
(150 x 4.6 mm, 2.6 µm) 
R~1.3 
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fully-porous columns.  In order to implement a next generation platform ion-pair RPLC 
method for ongoing analysis of routine research samples, we performed a column 
stability study to evaluate the long-term stability of these columns when used with the 
ion-pair RPLC method with pH 7 mobile phase and an elevated column temperature of 
60 °C.  The higher column temperature is important because at lower temperatures RNA-
based oligonucleotides are known to adopt more stable higher order conformations that 
can result in broad peaks and poor resolution, thereby considerably complicating 
analysis.  By increasing the column temperature to 60 °C or higher, the interconversion 
of these conformers becomes rapid, leading to sharp peaks and better separation [27, 28]. 
Unfortunately, the long-term column stability results showed that all core-shell 
columns evaluated were only moderately stable.  A representative column stability test 
with one of those core-shell columns showed excellent peak shape and resolution of 
minor components in the initial injection, but significant peak broadening and loss of 
resolution of critical impurities by the 100th injection (Figure 3.8).  In addition, the 
column inlet pressure steadily increased as more injections were made, limiting the 
practical use of the column. 
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Figure 3.8 Long-term column stability of Kinetex C18 column. 
IP-RPLC method conditions:  Kinetex C18 column (100 x 3 mm i.d. and 1.7 µm core-
shell particles).  The mobile phase consisted of 100 mM TEAA in water (mobile phase 
A) and 100 mM TEAA in acetonitrile (mobile phase B).  A gradient method of 10-25%B 
over 10 minutes, then 25%B to 60%B in 2 minutes (to elute late eluting impurities) and 3 
minutes post column equilibration at 10%B was used.  The flow rate was 0.6 mL/min, the 
column temperature was 60 °C, UV detection was set at 260 nm, and injection volume 
was 2 µL.  Atlas chromatographic system was used for system control and data 
processing. 
 
 
 
The long term instability of silica-based columns with high pH (e.g., >pH 8) 
mobile phases is well-known, where phase degradation and loss of column performance 
is attributed to dissolution of the underlying silica support [29].  In addition, silica 
dissolution at neutral to slightly basic pH can also be significant at elevated column 
temperatures [30], making the analysis of oligonucleotides challenging given the typical 
operating conditions of pH 7 and ≥60 °C.  The higher column temperature helps to 
effectively ‘melt’ these structures, while also increasing mass transfer for these relatively 
large molecules (about 7-8 kDa), thereby providing sharper peaks and improved 
resolution of closely eluting impurities [28]. 
A newly introduced core-shell C18 column (SunShell C18) [31] was evaluated for 
potential improvement in both resolution of closely related impurities and long-term 
column stability.  The SunShell C18 column is packed with 2.6 µm particle diameter 
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core-shell particles consisting of a 1.6 µm solid core surrounded by a 0.5 µm porous 
shell.  The SunShell C18 column is prepared with special end-capping chemistry that is 
reported to make this column more stable when operating at high pH and high column 
temperatures.  Vendor studies had shown that this column can be stable when tested with 
pH 10 mobile phase and elevated column temperature of 50 °C [32]. 
We investigated the SunShell C18 column for oligonucleotide analysis using an 
IP-RPLC method consisting of neutral pH 7 mobile phase and elevated column 
temperature of 65 °C [33].  Samples of a 21-mer oligonucleotide containing several 
minor impurities were repeatedly injected on the column and the retention and resolution 
were monitored over time.  The results illustrated in Figure 3.9 show that the column 
remains stable up to at least 300 injections, or greater than 5,000 mL of elution volume. 
 
 
 
Figure 3.9 Long-term column stability of SunShell C18 column. 
IP-RPLC method conditions:  SunShell C18 column (150 x 4.6 mm i.d. and 2.6 µm core-
shell particles).  The mobile phase consisted of 100 mM TEAA in water (mobile phase 
A) and 100 mM TEAA in acetonitrile (mobile phase B).  A standard linear gradient 
method of 5-25%B over 10 minutes with 5 minutes post column equilibration at 5%B 
was used.  The flow rate was 1.5 mL/min, the column temperature was 65 °C, UV 
detection was set at 260 nm, and injection volume was 5 µL.  Empower 2 
chromatographic system was used for system control and data processing. 
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These results show that the new SunShell C18 column provides a significant 
improvement over previously studied core-shell C18 columns for the chromatographic 
separation of oligonucleotide samples by IP-RPLC.  The new column provided the 
excellent peak shape, resolution and low backpressure seen with other core-shell 
columns, but also showed sufficient stability at neutral pH and high temperature to allow 
it to be a practical tool for routine oligonucleotide analysis. 
 
3.4 Conclusions 
In this study, a systematic evaluation of core-shell particle columns for improved 
analysis and separation of RNA oligonucleotide samples by IP-RPLC was performed, 
comparing various core-shell particle columns with differing particle and pore sizes with 
each other and the fully-porous particle column that was used as a control.  The results 
showed significant improvement in peak shape and separation of closely eluting 
impurities for the core-shell columns when analyzing RNA oligonucleotide samples.  The 
comparison results for core-shell (Kinetex C18 column) and fully-porous particles (Luna 
C18 (2) column) of comparable diameter showed much narrower peak width (measured 
at base) for core-shell particles (0.10 min compared to 0.17 min for fully-porous 
particles).  This resulted in significant improvement in separation when using core-shell 
particles, where fully-porous particles provided resolution of about 1.1 for the separation 
of the impurity eluting on the tail of the main peak, and core-shell particles provided 
much improved resolution of about 2.0.  The comparison of different core-shell C18 
columns showed the best peak shape with Kinetex XB-C18 column, where peak widths 
(measured at base) for the main component were 0.26 min for Ascentis Express C18 
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column, 0.18 min for Poroshell EC-C18 column and 0.13 min for the Kinetex XB-C18 
column.  The more recent sub-2 µm core-shell Kinetex C18 column provided even 
greater separation efficiency where more peaks could be separated from the complex 
peak clusters for these samples. 
However, the significant extra column volume contributions from the 
conventional HPLC instruments need to be considered.  With careful modifications to the 
instrument to minimize the extra column volume contributions, the sub-2 µm core-shell 
particles columns can be used with conventional HPLC instruments for improved 
analysis and separation of oligonucleotide samples. 
All of these columns, however, showed poor long-term stability at the operating 
conditions of neutral pH mobile phase and elevated column temperatures of ≥60 °C.   A 
new core-shell C18 column, the SunShell C18, consisting of 2.6 µm diameter particles 
with a 1.6 µm solid core surrounded by a 0.5 µm porous layer with special end-capping 
to promote column stability at high pH and elevated column temperatures, showed 
excellent resolution of oligonucleotide samples with considerably improved column 
stability.  A long-term stability test with neutral pH 7 mobile phase and elevated column 
temperature of 65 °C showed that the column remained stable after more than 300 
injections.  This is a significant improvement in long-term column stability and it 
provides another more practical analytical tool for routine analysis and separation of 
complex oligonucleotide samples. 
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Chapter 4: Factors Influencing the Separation of Oligonucleotides Using Reversed-
Phase / Ion-Exchange Mixed-Mode High Performance Liquid Chromatography 
Columns 
 
4.1 Introduction 
Strong anion-exchange liquid chromatography (SAX-LC) is one of the preferred 
methods for analyzing oligonucleotide samples [1-3].  In SAX-LC, separation is mainly 
based on differences in charge, with analytes of greater charge being more strongly 
retained on the column. This method is well suited for the analysis of N-x deletions, 
which are a major type of oligonucleotide impurities that are produced from the failed 
addition of one of the nucleotides during the synthesis process.   As such, shorter 
oligonucleotides have progressively fewer negative charges and have progressively 
shorter retention, resulting in a good separation with SAX-LC method.  At the same time, 
SAX-LC is poorly suited for detecting other possible impurities, such as depurinated 
oligonucleotides, other base modifications, or more subtle isomeric changes like an 
inversion of two bases in the sequence. 
Ion-pair reversed phase liquid chromatography (IP-RPLC) is another common LC 
method used for oligonucleotide analysis [4-6].  In IP-RPLC, negative charges on the 
oligonucleotide phosphate backbone are neutralized by positively charged 
alkylammonium ions in the mobile phase.  Hydrophobic interactions between the 
oligonucleotide bases and the reversed phase column play a major role in the separation, 
and the differing hydrophobicity of the individual bases contributes to differences in 
retention. As such, IP-RPLC is better suited for detecting any changes in the full-length 
sequence, such as depurinations, base changes, or other subtle changes on the sequence. 
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Overall, due to the differences in the separation mechanisms of SAX-LC and IP-
RPLC methods for oligonucleotide analysis, these two separation modes are typically 
considered as complementary [7-9], and often both methods must be utilized for 
complete analysis and characterization of oligonucleotide samples.  Recently developed 
mixed-mode columns having both reversed phase and ion exchange properties, however, 
offer the potential to combine the benefits of both separation methods in a single analysis. 
Mixed mode chromatography is a type of analysis in which multiple interaction 
modes can take place in a single stationary phase, with each interaction contributing to 
the retention of the analyte [10, 11].  At the same time, the use of mixed-mode columns 
in oligonucleotide analysis presents its own challenges, as all possible interactions 
between ligands and different functional groups of the oligonucleotide must be 
considered, with interactions between the different separation modes potentially creating 
unpredictable or undesirable results. In this study, a variety of oligonucleotide standards 
were evaluated using recently commercialized mixed-mode columns.  Different factors 
that influence the separation of oligonucleotides were investigated, including type and 
strength of mobile phases and type and strength of ion exchange ligands on the columns. 
 
4.2 Experimental 
4.2.1 Reagents and materials 
Ammonium acetate, triethylammonium acetate buffer (TEAA, 1M concentration), 
sodium chloride, sodium bromide, and trizma hydrochloride buffer solution (pH 7.4, 1M 
concentration) were purchased from Sigma-Aldrich (St. Louis, MO, USA).  Acetonitrile 
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(HPLC grade) was purchased from Fisher Scientific (Fair Lawn, NJ, USA).  Ethanol 
(HPLC grade denatured with 5% IPA and 5% MeOH) was purchased from Sigma-
Aldrich (St. Louis, MO, USA).  Deionized water was purified using Hydro ultra-pure 
water purification system (Garfield, NJ, USA). 
The oligonucleotide sample libraries were synthesized by Merck RNA synthesis 
group.  The samples were prepared at about 1 mg scale and purified by SAX-LC 
purification method. 
 
4.2.2 Separation columns 
The separation columns used in these studies included the following:  Proteomix 
SAX-NP3 (150 mm x 4.6 mm i.d., 3 µm particle size) column for SAX-LC (Sepax 
Technologies, Newark, DE, USA), XBridge C18 (150 mm x 4.6 mm i.d., 3.5 µm particle 
size) column for IP-RPLC (Waters, Milford, MA, USA).  The mixed-mode columns 
were:  Scherzo SW-C18, Scherzo SM-C18, and Scherzo SS-C18 (all 150 mm x 4.6 mm 
i.d., 3 µm particle size) columns for mixed-mode chromatography (Imtakt, Philadelphia, 
PA, USA).  More information for these columns is provided in Table 3.3. 
 
4.2.3 Instrumentation 
All samples were analyzed using an Agilent 1100 HPLC (Agilent, Palo Alto, CA, 
USA) instrument consisting of binary pump, degasser, autosampler, column oven, and 
variable wavelength detector (VWD).  Atlas Chromatographic System (Thermo 
Scientific, Waltham, MA, USA) was used for system control and data processing (for all 
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results except results illustrated in Figure 4.2).  An Empower II chromatographic system 
(Waters, Milford, MA, USA) was used for system control and data processing (results in 
Figure 4.2 only). 
 
4.2.4 Chromatographic conditions 
The method conditions were adjusted for each separation example and the 
detailed chromatographic conditions are listed in the corresponding figures. 
 
4.3 Results and discussion 
4.3.1 Oligonucleotide sample library 
In order to assess the use of reversed phase / ion exchange mixed-mode columns 
for the chromatographic separation of oligonucleotide mixtures, a sample set consisting 
of a family of ribonucleic acid (RNA) oligomers including a 21-mer parent based on 
siApoB-1 sense strand reported by Zimmermann et al. [12], and sequential deletions from 
the 5' end (N-1, N-2, to N-15) (Table 4.1), was prepared.  These N-x deletion samples 
represent one of the major impurity classes observed in oligonucleotide synthesis, where 
the failure of a single nucleotide to attach to the sequence during synthesis is a relatively 
common occurrence.  As automated oligonucleotide synthesis typically proceeds from 
the 3’ to the 5’ direction, N-x deletions from the 5’ end are most likely to exist in the final 
product.  The individual members of this sample set differ in molecular weight and the 
total number of charged residues, and are fairly easy to resolve by a number of 
chromatographic techniques.  
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Table 4.1 Library of RNA oligonucleotides with N-x deletions. 
 
Sample RNA Sequence 
21-mer 5’-GUCAUCACACUGAAUACCAAU-3’ 
N-1   5’-UCAUCACACUGAAUACCAAU-3’ 
N-2      5’-CAUCACACUGAAUACCAAU-3’ 
N-3         5’-AUCACACUGAAUACCAAU-3’ 
N-4            5’-UCACACUGAAUACCAAU-3’ 
N-5               5’-CACACUGAAUACCAAU-3’ 
N-6                  5’-ACACUGAAUACCAAU-3’ 
N-7                     5’-CACUGAAUACCAAU-3’ 
N-8                        5’-ACUGAAUACCAAU-3’ 
N-9                           5’-CUGAAUACCAAU-3’ 
N-10                              5’-UGAAUACCAAU-3’ 
N-11                                 5’-GAAUACCAAU-3’ 
N-12                                    5’-AAUACCAAU-3’ 
N-13                                       5’-AUACCAAU-3’ 
N-14                                          5’-UACCAAU-3’ 
N-15                                             5’-ACCAAU-3’ 
 
 
 
In addition to the study of these grossly dissimilar deletion oligonucleotides, a 
sample set consisting of mixtures with more subtle differences was also included.  Small 
differences in oligonucleotide structure arising from depurination, chemical modification, 
or single nucleotide substitution are also an important class of possible impurities that are 
relevant to modern oligonucleotide analysis.  A family of isomeric oligonucleotides 
representing the most challenging of these separations was prepared (Table 4.2).  These 
21-mer RNA sequences have identical overall composition, charge and molecular weight; 
however the order of two neighboring bases were purposely reversed at various positions 
within the sequence.  Chromatographic separation of these ‘base-flip’ isomers was 
expected to be somewhat challenging. 
 
 
  
109 
 
Table 4.2 Subtly different isomeric RNA 21-mers based on ApoB-1 sense strand.  In each 
isomeric oligonucleotide the order of two neighboring bases has been reversed.   
 
Sample RNA Sequence 
21-mer 5'-GUCAUCACACUGAAUACCAAU-3' 
Isomer 1 5'-UGCAUCACACUGAAUACCAAU-3' 
Isomer 2 5'-GUCACUACACUGAAUACCAAU-3' 
Isomer 3 5'-GUCAUCACACGUAAUACCAAU-3' 
Isomer 4 5'-GUCAUCACACUAGAUACCAAU-3' 
Isomer 5 5'-GUCAUCACACUGAAUACCAUA-3' 
 
 
 
4.3.2 Comparison of SAX-LC and IP-RPLC 
 
The oligonucleotide samples were first analyzed with the conventional, 
complementary LC techniques of SAX-LC and IP-RPLC.  Chromatographic conditions 
were optimized to give the best separation results with each method.  SAX-LC analysis 
of the N-X deletion sample set showed the expected trend of decreasing retention for 
shorter oligonucleotides, highlighting the importance of total charge for retention (Figure 
4.1a).  In contrast, the base-flip isomers were essentially unresolved, presumably owing 
to the fact that they all have identical charge (Figure 4.1b). 
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Figure 4.1 Chromatographic separation of oligonucleotide standards by SAX-LC.  a)  
Separation of N-X deletion series, b)  Separation of ‘base-flip’ isomer standards (25-29 
min portion of chromatogram shown).  SAX-LC method conditions:  Proteomix SAX-
NP3 column (150 mm length x 4.6 mm i.d. and 3 µm particle size).  The mobile phase 
consisted of 80% v/v% of 10 mM Tris with pH 8 buffer and 20% v/v% ethanol (mobile 
phase A), and 600 mM sodium bromide salt concentration in mobile phase A (mobile 
phase B).  A standard linear gradient method of 20-80% mobile phase B over 30 minutes 
with 5 minutes post column equilibration at 20% B was used.  The flow rate was 0.5 
mL/min, the column temperature was 60 °C, the injection volume was 15 µL, and UV 
detection was set at 260 nm. 
 
 
 
In IP-RPLC, in addition to the charge-charge interactions, hydrophobic 
interactions are also introduced in the separation mechanism and overall retention is 
based on the differences of the charges on the RNA strand as well as the differences in 
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hydrophobicities from the different bases.  As a result, the retention trend when analyzing 
oligonucleotides with IP-RPLC can be somewhat complex (Figure 4.2a).  As reported by 
Oefner [13], the hydrophobicity of oligonucleotide bases is generally in the order of 
C<G<A<T (for DNA based oligonucleotides), where cytosine is the least hydrophobic 
base, followed by guanine and adenine. 
In general, oligonucleotide retention decreased with each N-1 deletion, except for 
cytosine base deletions, which actually resulted in an increase in retention.  For example, 
compare N-2 and N-3, N-5 and N-6, N-7 and N-8 (Figure 4.2a).  In addition, loss of the 
next least hydrophobic base, guanine, also led to an increase in retention (compare N-11 
and N-12).  Overall, even though the retention trends can be quite complicated, the N-X 
deletions are generally well separated using the IP-RPLC method. 
Interestingly, analysis of the base-flip isomers using the IP-RPLC method showed 
modest separations for these very challenging analytes (Figure 4.2b).  Since these 
analytes contain the same number of charges and are comprised of the same bases (they 
are technically structural isomers) the separation and retention differences must be 
attributed to subtle differences in conformations.  Evaluation of the base-flip isomers 
using different column temperatures from 25 °C to 65 °C at increments of 10 °C is shown 
in Appendix A.   
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Figure 4.2 Chromatographic separation of oligonucleotide standards by IP-RPLC.  a)  
Separation of N-X deletion series, b)  Separation of ‘base-flip’ isomer standards (11-15 
min portion of chromatogram shown).  IP-RPLC method conditions:  XBridge C18 
column (150 mm length x 4.6 mm i.d. and 3.5 µm particle size).  The mobile phase 
consisted of 100 mM TEAA in water (mobile phase A), and 100 mM TEAA in 
acetonitrile (mobile phase B).  A standard linear gradient method of 5-10% mobile phase 
B over 15 minutes with 5 minutes post column equilibration at 5% B was used.  The flow 
rate was 1.5 mL/min, the column temperature was 65 °C, the injection volume was 15 
µL, and UV detection was set at 260 nm.  Empower II chromatographic system was used 
for system control and data processing. 
 
 
 
A single chromatographic method that could afford predictable separations of N-x 
deletions while also being able to resolve the more challenging base-flip isomers would 
be ideal.  Therefore, new mixed-mode stationary phases were investigated, which are a 
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hybrid of reversed-phase and ion-exchange stationary phases.  The observation of a trend 
in retention for N-x deletion samples similar to that afforded by SAX-LC separation 
would suggest that ion-exchange interactions are dominant.  In contrast, a specific 
retention trend for IP-RPLC alone along with some partial separation for the base-flip 
samples would suggest ion-pair reversed phase interaction mode is dominant.  Ideally, the 
mixed-mode columns would show benefits of both separation modes.  The dominating 
interaction mode could be influenced by different factors, such as the type and strength of 
ion exchange ligands on the column and the type and strength of ions in the mobile 
phase. 
 
4.3.3 Mixed-mode chromatography for oligonucleotide separation 
Mixed-mode chromatography is a type of separation method in which multiple 
interaction modes take place between the stationary phase and the analytes.  In this 
separation technique, the stationary phase contains two or more interaction sites.  Mixed-
mode stationary phases can be constructed by connecting two different columns in series 
(tandem column), by packing two different stationary phases into the same column 
(biphasic column), or by synthesizing a stationary phase with two or more discrete 
interaction sites [14].  Mixed-mode columns consisting of ion-exchange and C18 selectors 
are an obvious choice for oligonucleotide analysis, and early work along these lines has 
been reported by McLaughlin [15]. 
Recently, several mixed-mode columns consisting of ion-exchange and C18 
selectors have been commercialized, and we report here on the evaluation of these new 
columns for RNA oligonucleotide analysis.  The first column, Scherzo SW-C18, is 
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prepared by mixing two types of bonded silica particles:  one containing C18 silanes and a 
low amount of strong anion exchanger and the other containing C18 silanes and a low 
amount of a strong cation exchanger (Table 4.3). The second column, Scherzo SM-C18, 
is prepared by mixing particles with C18 silanes and a weak anion exchanger with 
particles containing C18 silanes and a weak cation exchanger. The third column, Scherzo 
SS-C18, is prepared by mixing particles containing C18 silanes and large amounts of a 
strong anion exchanger with particles containing C18 silanes and large amounts of a 
cation exchanger.  All columns were 150 mm length x 4.6 mm i.d., containing 3 µm 
particles with 130 Å average pore sizes. 
 
 
Table 4.3 Mixed-mode chromatography columns evaluated included Scherzo SW-C18, 
SM-C18, and SS-C18.  SAX=Strong anion exchange, SCX=strong cation exchange, 
WAX=weak anion exchange, WCX=weak cation exchange. 
 
Column name Column description 
Scherzo SW-C18 
Scherzo SM-C18 
Scherzo SS-C18 
C18 column with low ion-exchange capacities of SAX and SCX 
C18 column with medium ion-exchange capacities of WAX and WCX 
C18 column with high ion-exchange capacities of SAX and SCX 
 
 
 
Analysis of oligonucleotide mixtures using the Scherzo SW-C18 mixed-mode 
column was initially performed using the ammonium acetate gradient elution method 
recommended by the vendor [16].  The results illustrated in Figure 4.3 show significant 
peak tailing, especially for the longer retained analytes.  Furthermore, the results appear 
to be dominated by the IP-RPLC separation mode, with retention patterns very similar to 
what was previously observed in the IP-PRLC mode alone (Figure 4.3a). 
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Figure 4.3 Chromatographic separation of RNA oligonucleotide samples by mixed mode 
chromatography using Scherzo SW-C18 column with ammonium acetate gradient.  a)  
Separation of N-X deletion series, b)  Separation of ‘base-flip’ isomer standards (20-50 
min portion of chromatogram shown).  Conditions: The mobile phase consisted of 10 
mM ammonium acetate (mobile phase A) and 200 mM ammonium acetate in 15% 
acetonitrile/water (mobile phase B).  A linear gradient of 20-50% B over 60 minutes was 
used.  The flow rate was 1 mL/min, column temperature was 50 °C, the injection volume 
was 10 µL and the UV detection was set at 260 nm.   
 
 
 
It was suspected that the poor peak shape could be caused due to the presence of 
ammonium ion, which is less well suited for IP-RPLC of oligonucleotides owing to the 
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lack of hydrophobic interaction.  The use of triethylammonium acetate (TEAA) as an ion-
pairing reagent was evaluated next, as this is one of the most routinely used ion-pairing 
reagents for IP-RPLC analysis of oligonucleotides by UV detection [17, 18].  The TEAA 
gradient chromatography afforded much improved peak shape and resolution, as 
illustrated in Figure 4.4.  However, the results again indicated that retention is 
predominantly by the IP-RPLC interaction mode, with the characteristic retention shift 
pattern for the N-x deletion samples and partial separation for the base-flip isomers 
showing the characteristic pattern observed in Figure 4.3. 
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Figure 4.4 Chromatographic separation of RNA oligonucleotide samples by mixed mode 
chromatography using Scherzo SW-C18 column with triethylammonium acetate (TEAA) 
gradient.  a)  Separation of N-X deletion series, b)  Separation of ‘base-flip’ isomer 
standards (25-35 min portion of chromatogram shown).  Conditions: The mobile phase 
consisted of 10 mM TEAA in water (mobile phase A) and 200 mM TEAA in 15% 
acetonitrile/water (mobile phase B).  A linear gradient of 40-85% B over 45 minutes was 
used.  The flow rate was 1 mL/min, column temperature was 50 °C, the injection volume 
was 10 µL and the UV detection was set at 260 nm.   
 
 
 
In order to enhance the contribution of the ion exchange separation mode, the 
mobile phase conditions were changed to more typical SAX-LC conditions including the 
use of sodium chloride (NaCl) or sodium bromide (NaBr) salt gradients. An interesting 
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and somewhat unexpected separation trend for the oligonucleotide test mixtures was 
observed with the NaCl salt gradient (Figure 4.5).  The N-x standards showed a very 
different retention pattern from that previously observed with ammonium acetate or 
TEAA eluents (Figure 4.5a).  Interestingly, the resolution of the base-flip isomers was 
surprisingly good (with co-elution of only two isomers), and with significant 
improvement in peak shape (Figure 4.5b). 
 
 
 
Figure 4.5 Chromatographic separation of RNA oligonucleotide samples by mixed mode 
chromatography using Scherzo SW-C18 column with NaCl gradient.  a)  Separation of  
ssRNA (ApoB1) (2,1) Pr_siRNA,RY_LC-223.jiange_120626_NaCl35-65,2,1,1
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Figure 4.5 (continued) 
N-X deletion series, b)  Separation of ‘base-flip’ isomer standards.  Conditions: The 
mobile phase consisted of:  100 mM Tris pH 7.4 in water (mobile phase A) and 1M NaCl 
in 100 mM Tris pH 7.4 water/Acetonitrile (90/10 v/v %).  It is also important to note that 
Tris buffer (at pH 7.4) was used because the Tris buffer components are neutral or 
positively charged and therefore do not compete or interfere with the anion exchange of 
the chloride anion. A linear gradient of 35-65% B over 30 minutes was used.  The flow 
rate was 1 mL/min, column temperature was 50 °C, the injection volume was 10 µL and 
the UV detection was set at 260 nm.   
 
 
 
Next, the Scherzo SM-C18 column was evaluated, which contains both weak 
cation and anion exchangers, but at higher concentrations than the strong cation and 
anion exchangers in the SW-C18 column.  The use of ammonium acetate or TEAA 
eluents with this column was ineffective for the elution of most oligonucleotides, with 
only the smallest N-15 compound eluting under these conditions.  Use of the 1M NaCl 
eluent did lead to elution of all sample components, however with significantly increased 
retention.  The use of 2M NaCl provided improved elution of the oligonucleotides with 
this column, as illustrated in Figure 4.6.  The retention and separation trend of the 
oligonucleotide samples (deletions and base-flip isomers) was still very similar to that 
observed with the Scherzo SW-C18 column (Figure 4.5), suggesting that although the ion 
exchange mechanism is clearly important for bulk retention, the differential retention 
pattern observed for the samples is different from the IP-RPLC or SAX-LC separations 
alone.  The use of the stronger bromide anion in the mobile phase provided adequate 
elution with only 1M NaBr (chromatograms not shown), comparable to the results 
obtained with 2M NaCl. 
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Figure 4.6 Chromatographic separation of RNA oligonucleotide samples by mixed mode 
chromatography using Scherzo SM-C18 column with NaCl gradient.  a)  Separation of N-
X deletion series, b)  Separation of ‘base-flip’ isomer standards.  Conditions: The mobile 
phase consisted of:  100 mM Tris pH 7.4 in water (mobile phase A) and 2M NaCl in 100 
mM Tris pH 7.4 water/Acetonitrile (90/10 v/v %).  A linear gradient of 50-85% B over 
35 minutes was used.  The flow rate was 1 mL/min, column temperature was 50 °C, the 
injection volume was 3 µL and the UV detection was set at 260 nm.   
 
 
 
Overall, in addition to the retention pattern and separation differences observed 
with the SW-C18 and SM-C18 columns when used with SAX-LC like mobile phase 
conditions consisting of NaCl or NaBr salt gradients, there was also a significant 
improvement in peak shape.  Comparison of the calculated peak widths (calculated at half 
peak height) and peak tailing factors are illustrated in Table 4.4.  The results showed the 
ssRNA (ApoB1) (2,1) Pr_siRNA,RY_LC-296.jiange_120712_2MNaClSM50-85,2,1,1
Acquired Thursday, July 12, 2012 6:32:34 PM
0
10
20
30
40
50
60
70
80
90
100
R
e
sp
o
n
se
0 5 10 15 20 25 30 35
Retention time
21-mer:  5’-GUCAUCACACUGAAUACCAAU-3’
N-1:         5’-UCAUCACACUGAAUACCAAU-3’
N-2:         5’-CAUCACACUGAAUACCAAU-3’
N-3:         5’-AUCACACUGAAUACCAAU-3’
N-4:         5’-UCACACUGAAUACCAAU-3’
N-5:         5’-CACACUGAAUACCAAU-3’
N-6:         5’-ACACUGAAUACCAAU-3’
N-7:         5’-CACUGAAUACCAAU-3’
N-8:         5’-ACUGAAUACCAAU-3’
N-9:         5’-CUGAAUACCAAU-3’
N-10:       5’-UGAAUACCAAU-3’
N-11:       5’-GAAUACCAAU-3’
N-12:       5’-AAUACCAAU-3’
N-13:       5’-AUACCAAU-3’
N-14:       5’-UACCAAU-3’
N-15:       5’-ACCAAU-3’
a
ssRNA (ApoB1) (2,1) Pr_siRNA,RY_LC-296.jiange_120712_2MNaClSM50-85,2,1,1
Acquired Thursday, July 12, 2012 6:32:34 PM
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
R
e
sp
o
n
se
0 5 10 15 20 25 30 35
Retention time
21-mer:  5’-GUCAUCACACUGAAUACCAAU-3’
Isomer 1:  5’-UGCAUCACACUGAAUACCAAU-3’
Isomer 2:  5’-GUCACUACACUGAAUACCAAU-3’
Isomer 3:  5’-GUCAUCACACGUAAUACCAAU-3’
Isomer 4:  5’-GUCAUCACACUAGAUACCAAU-3’
Isomer 5:  5’-GUCAUCACACUGAAUACCAUA-3’
b
121 
 
best peak shape with the Scherzo SM-C18 column, with an average peak width of 13.06 s 
and an average tailing factor of 1.08 when a NaCl salt gradient was employed. 
 
 
Table 4.4 Comparison of Scherzo SW-C18 and SM-C18 columns using SAX-LC 
conditions with NaCl and NaBr salt gradients.  The retention times, peak widths and peak 
tailing factors were obtained using Atlas Chromatographic system.  The peak widths 
were calculated at peak half height.  *The peak tailing factors were corrected for results 
less than 1.00 where a reciprocal (1/x) was calculated for a better comparison and 
reporting of average peak tailing factors.    
 
Column:  Scherzo SW-C18 
Mobile Phase:  1M NaCl Mobile Phase:  1M NaBr 
Sample 
Name 
tR (min) Peak 
width 
(s) 
Peak 
tailing
*
 
Sample 
Name 
tR (min) Peak 
width 
(s) 
Peak 
tailing
*
 
21-mer 21.12 13.90 1.24 21-mer 21.12 14.79 1.48 
N-1 19.81 13.96 1.07 N-1 19.54 14.48 1.06 
N-2 20.00 13.67 1.03 N-2 19.82 14.50 1.14 
N-3 23.20 13.78 1.01 N-3 23.00 14.13 1.02 
N-4 18.84 13.90 1.02 N-4 18.46 14.14 1.06 
N-5 18.79 13.81 1.03 N-5 18.45 14.36 1.03 
N-6 21.96 13.75 1.04 N-6 21.76 14.44 1.02 
N-7 17.77 13.51 1.18 N-7 17.43 13.87 1.35 
N-8 20.60 13.45 1.11 N-8 20.29 13.82 1.15 
N-9 16.06 13.16 1.20 N-9 15.68 13.53 1.27 
N-10 17.44 13.23 1.23 N-10 16.92 13.61 1.32 
N-11 19.69 13.26 1.23 N-11 19.31 13.69 1.25 
N-12 22.56 13.40 1.30 N-12 21.94 13.69 1.32 
N-13 17.77 12.61 1.33 N-13 16.94 12.87 1.37 
N-14 11.29 10.64 1.39 N-14 10.45 10.62 1.43 
N-15 11.99 10.73 1.39 N-15 11.38 10.81 1.43 
Average - 13.17 1.18 Average - 13.58 1.23 
% RSD - 7.8 11.4 % RSD - 9.0 13.1 
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Table 4.4 (continued) 
Column:  Scherzo SM-C18 
Mobile Phase:  2M NaCl Mobile Phase:  1M NaBr 
Sample 
Name 
tR (min) Peak 
width (s) 
Peak 
tailing
*
 
Sample 
Name 
tR (min) Peak 
width (s) 
Peak 
tailing
*
 
21-mer 13.83 15.33 1.08 21-mer 13.36 15.78 1.16 
N-1 12.59 14.70 1.06 N-1 12.06 14.88 1.13 
N-2 12.85 14.56 1.14 N-2 12.36 13.85 1.07 
N-3 15.93 14.62 1.05 N-3 15.27 14.73 1.15 
N-4 11.69 14.18 1.06 N-4 11.27 14.35 1.14 
N-5 11.70 13.90 1.08 N-5 11.34 14.27 1.14 
N-6 14.72 14.59 1.08 N-6 14.25 14.57 1.47 
N-7 10.67 13.45 1.02 N-7 10.49 13.74 1.21 
N-8 13.25 13.64 1.02 N-8 12.93 13.61 1.14 
N-9 9.18 12.53 1.01 N-9 9.04 12.34 1.11 
N-10 10.34 12.68 1.04 N-10 10.15 12.52 1.08 
N-11 12.32 13.16 1.04 N-11 12.19 12.94 1.11 
N-12 14.87 13.25 1.09 N-12 14.65 13.21 1.10 
N-13 10.80 11.56 1.11 N-13 10.69 11.56 1.07 
N-14 6.20 8.25 1.14 N-14 6.24 8.28 1.07 
N-15 6.88 8.61 1.20 N-15 7.02 9.01 1.07 
Average - 13.06 1.08 Average - 13.10 1.14 
% RSD - 15.7 4.8 % RSD - 15.6 8.5 
 
 
 
Lastly, the Scherzo SS-C18 column was evaluated for oligonucleotide analysis by 
mixed-mode chromatography.  The Scherzo SS-C18 column contains higher 
concentrations of strong anion and cation exchange sites compared to the previous 
columns.  It was expected that the greater number of the ion exchange functional groups 
on the column would significantly increase the strong anion exchange interaction with the 
oligonucleotide samples.  Evaluation of this column with the previous mobile phases 
consisting of 2M NaCl or 1M NaBr, and even increased mobile phase strength to 2M 
NaBr yielded no results, i.e., there was no elution of any of the oligonucleotides.  Due to 
the very strong ion interactions between this column and the oligonucleotides, this 
column was deemed unsuitable for oligonucleotide analysis. 
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4.4 Conclusions 
The results of this investigation suggest that mixed-mode columns are capable of 
both reversed-phase and ion-exchange separation modes and may be of some value for 
improved analysis and separation of oligonucleotides, allowing a single column and 
method to replace the two columns and methods typically used for complete 
oligonucleotide analysis.  While initial studies using the vendor-recommended 
ammonium acetate or triethylammonium acetate gradients appear to be dominated by the 
ion-pair reversed phase separation mode, changing the mobile phase to more typical 
anion-exchange conditions such as salt gradients with NaCl or NaBr affords a very 
different retention trend for the N-x deletion samples. 
Interestingly, the resolution of a group of challenging isomeric oligonucleotides is 
surprisingly improved with the mixed-mode columns, affording separations that are 
better than either the ion-pair reversed phase or the ion-exchange mode alone. The 
mixed-mode columns with SAX-LC conditions also showed significantly improved peak 
shape.  Comparison of the Scherzo SW-C18 and Scherzo SM-C18 columns with NaCl or 
NaBr salt gradients showed the best peak shape with Scherzo SM-C18 and NaCl mobile 
phase.  It remains to be seen whether these new mixed-mode columns will also provide 
general improvements for other complex oligonucleotide separations. 
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Chapter 5: Preparation of RNA-Modified Silica Columns for Evaluation in Affinity 
Chromatography of Oligonucleotide Separations 
 
5.1 Introduction 
As research on the biomedical uses of short RNA oligonucleotides continues, we 
can expect ongoing development of improved methods to chromatographically analyze 
and purify these fascinating compounds.  Given the readiness with which these molecules 
engage in Watson-Crick base pairing with complementary oligonucleotide strands, 
affinity chromatography-like approaches in which a complementary oligonucleotide 
stationary phase is used for the targeted retention and chromatographic separation of 
particular oligonucleotide products may be possible for the analysis, and especially 
purification, of RNA oligonucleotides.  
Affinity chromatography purification of oligonucleotide binding proteins has been 
carried with an oligonucleotide affinity column (oligo (dT)12-18 cellulose) [1], and more 
recently, using a stationary phase consisting of 2’-fluoro modified RNA covalently linked 
to agarose beads [2].  Oligonucleotide hybridization has long been used in the formation 
of DNA microarrays and similar technologies [3, 4], and can reliably be used for 
selective capture of particular oligonucleotide sequences.  While these experiments 
involve only simple binding at lower temperature with release at elevated temperature, 
true chromatographic separation may be possible on complementary oligonucleotide 
stationary phases operated at elevated temperatures, or in the presence of mobile phase 
additives that make adsorption/desorption fast on the ‘HPLC timescale’.  Such stationary 
phases could, in principle, be tailor-made for certain analytical or purification tasks, for 
example, the selective binding of desired target single-stranded oligonucleotides, or of an 
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otherwise difficult to remove isomeric or closely related impurity.  Therefore, the goal of 
this research was to prepare RNA-modified stationary phases and evaluate them for the 
selective binding of desired oligonucleotide targets by an RNA-based affinity 
chromatography approach. 
 
5.2 Experimental 
5.2.1 Materials and reagents 
Solvents such as acetonitrile, anhydrous acetonitrile, dimethyl sulfoxide (DMSO), 
dichloromethane (DCM), and isopropanol (IPA) were all purchased from Sigma-Aldrich 
(St. Louis, MO, USA).  Deionized water was purified using Hydro ultra-pure water 
purification system (Garfield, NJ, USA).  Other reagents used to prepare mobile phases, 
such as phosphoric acid (85 wt% in water), ammonium phosphate (mono and dibasic), 
potassium phosphate, and triethylammonium acetate buffer (TEAA, 1M concentration) 
were all purchased from Sigma-Aldrich (St. Louis, MO, USA).  The test analytes, such as 
benzophenone and uracil were also purchased from Sigma-Aldrich (St. Louis, MO, 
USA).  Azido-dPEG4-NHS-ester (MW 388.37), azido-NHS-ester with shortest PEG 
length available, was purchased from Quanta Biodesign (Powell, Ohio, USA).  Copper (I) 
bromide dimethylsulfide complex was purchased from Sigma-Aldrich (St. Louis, MO, 
USA).  All oligonucleotide samples were synthesized by the Merck RNA synthesis 
group. 
128 
 
5.2.2 Stationary phase media and columns 
Kromasil C18 stationary phase media (with 10 µm particle size and 100 Å pore 
size) was purchased from AkzoNobel (Bohus, Sweden).  Chromegabond Amine 
stationary phase media (with 5 µm particle size and 300 Å pore size) was purchased from 
ES Industries (West Berlin, NJ, USA).   XBridge C18 column (150 mm x 4.6 mm i.d. and 
3.5 µm particle size) was purchased from Waters (Milford, MA, USA).  The empty 
capillary LC columns with 0.3 mm i.d. and 0.5 mm i.d. with 5 and 10 cm lengths, 
equipped with frits and column fittings, were gifts from Eksigent (Redwood City, CA, 
USA). 
 
5.2.3 Instrumentation 
The RNA oligonucleotide reaction mixtures were analyzed using an Agilent 1100 
HPLC (Palo Alto, CA, USA) instrument consisting of a binary pump, degasser, 
autosampler, column oven, and variable wavelength detector (VWD).  Waters Empower 
II chromatographic system (Milford, MA, USA) was used for system control and data 
processing.   
The RNA-modified columns were tested with an Eksigent Express LC-100 
microflow LC system (Redwood City, CA, USA), equipped with high pressure pumps, 
temperature controlled column holder, integrated injection system (10 nL-50 µL range), 
and microfabricated flow cell (200-380 nm array-based detector). 
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5.2.4 Chromatographic conditions  
Detailed chromatographic conditions are listed in the corresponding figure 
captions. 
 
5.3 RNA-modified silica column preparation strategies 
In order to prepare these novel RNA-modified silica stationary phases for 
evaluation in RNA-based affinity chromatography separation of oligonucleotides, 
different strategies were considered.  Due to the more limited amounts of RNA samples 
available (considering very long synthetic steps and expensive reagents), an efficient way 
for making these materials and packing them into columns needed to be evaluated.  
Initially, a simple calculation was performed to estimate the amounts of oligonucleotide 
samples needed for packing different size analytical columns.  First, column volumes for 
different size columns ranging from typical 4.6 mm i.d. to capillary 0.3 mm i.d., and  
with 5 cm to 15 cm length, were calculated (Table 5.1). 
 
 
Table 5.1 Column volumes (mL) for columns of different size (inner diameter and 
length).  Column volumes were calculated by using the equation for volume of a cylinder 
V = π r2L (where r = radius of column (cm) or column internal diameter/2, L = length of 
column (cm)). 
 
Column i.d. 
(mm) 
0.3 0.5 1 2 4.6 
5 cm length 0.0035 0.010 0.039 0.16 0.83 
10 cm length 0.0071 0.020 0.078 0.31 1.7 
15 cm length 0.011 0.030 0.12 0.47 2.5 
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Next, knowing the column volumes, the mass of packing material, such as bare 
silica with bulk density of 0.45 g/mL, was calculated for the different size columns. 
 
 
Table 5.2 Milligrams of packing material (based on Kromasil bare silica with bulk 
density of 0.45 g/mL) needed for different size columns.  Milligrams of packing material 
(or adsorbent) calculation:  column volume (mL) x packing bulk density (g/mL) x 10
-3
 
mg/g. 
 
Column i.d. 
(mm) 
0.3 0.5 1 2 4.6 
5 cm length 1.6 4.4 18 70 370 
10 cm length 3.2 8.8 35 140 750 
15 cm length 4.8 13 53 210 1100 
 
Then, assuming 0.1 mmol RNA per gram of silica loading onto the silica 
stationary phase (with about 8 kDA molecular weight), the required mass of RNA 
oligonucleotides was estimated for the different size columns. 
 
 
Table 5.3 Milligrams of RNA oligonucleotide needed for modifying silica and pack 
different size columns. 
 
Column i.d. 
(mm) 
0.3 0.5 1 2 4.6 
5 cm length 1.28 3.5 14.4 56 296 
10 cm length 2.56 7.04 28 112 600 
15 cm length 3.84 10.4 42.4 168 880 
 
 
 
Synthesis of RNA oligonucleotides using small scale automated synthesizers can 
provide about 500 nmol and up to about 1 µmol per synthetic cycle (including over 90 
chemical steps followed by purification), resulting in about 4 mg to 8 mg of RNA 
oligonucleotide.  Therefore, when designing these experiments, typical analytical 
columns with 4.6 mm i.d. requiring hundreds of milligrams of RNA are not practical, and 
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capillary LC columns with 0.5 mm i.d. or 0.3 mm i.d. requiring only a few mg of RNA 
samples needed to be considered. 
Packing good capillary columns with a small inner diameter, however, can be a 
challenging step.  In general, most column packing procedures in liquid chromatography 
are performed by using slurry packing techniques [5].  This packing technique is 
preferred compared to dry packing methods [6], for example, because the stationary 
phase particles tend to be dispersed in the solvent resulting in more efficient packing 
procedure.  However, the type of the slurry solvents used can greatly affect the stability 
of the slurry mixture, and the colloidal stability of the packing slurry mixture (i.e., the 
coagulating behavior of the stationary phase particles in that particular solvent) can be 
extremely important in slurry column packing process.  These colloidal stability effects 
are even more critical in packing capillary columns, such as 0.3 mm i.d. (300 µm), 
because of the higher value for the column length-to-column diameter (L/D) ratio (L/D = 
~300 for microcolumn with 0.3 mm i.d. and 100 mm length compared to L/D = ~20 for 
typical analytical size column with 4.6 mm i.d. and 100 mm length) [7, 8].  Therefore, 
when packing capillary columns, efforts should be made to minimize or avoid 
coagulation in the stationary phase particles in order to pack good columns. 
We custom-built a small column packing apparatus to be able to pack small 
capillary columns with 0.3 mm i.d. or 0.5 mm i.d. with the new RNA-modified stationary 
phases (Figure 5.1).  The column packing apparatus consisted of a Rheodyne valve with 
on/of switch connected to a 1260 Agilent LC pump (up to 600 bars pressure).  A slurry 
reservoir (with about 300 µL volume) was also custom-made from ¼-inch stainless steel 
tubing, where the inner surface was machined so that it had a cone shape resulting in 
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more efficient slurry packing.  Empty capillary LC columns were obtained from Eksigent 
and they were assembled with columns fittings and a frit at the end of the column. 
 
 
 
Figure 5.1 Custom-built column slurry packing apparatus for packing small capillary 
columns.  The column packing apparatus consisted of a Rheodyne valve with on/off 
switch, slurry reservoir that was machined with a cone inner surface, an empty column 
with fittings and a frit at the end of the column, and an Agilent 1260 LC pump for the 
solvent flow. 
 
 
 
The new column packer was first tested by packing a small 0.5 mm i.d. with 5 cm 
length capillary column using Kromasil C18 stationary phase (10 µm particle size and 
100 Å average pore size, bulk density 0.66 g/mL).  The slurry packing solvent was 
isopropanol (IPA), and the column packing with different amounts of stationary phase 
was tested.  A slurry mixture prepared by using 50 mg (or about 10 times excess of 
packing material) of Kromasil C18 in 300 µL IPA was packed into a small capillary 
column with 0.5 mm i.d. and 5 cm length using the slurry packing apparatus.  The 
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column was then tested using the Eksigent Nano LC instrument and a RPLC method.  
The RPLC method conditions consisted of:  0.1% phosphoric acid (pH 2) as the aqueous 
mobile phase A, and acetonitrile as the organic mobile phase B.  The method used 
isocratic conditions of 40%A/60%B, 20 µL/min flow rate, column temperature at 25 °C, 
and 90 nL injection volume.  The test analyte was a mixture of uracil (used as a void 
marker) and benzophenone (1 mg/mL in 50/50 water/acetonitrile).  The test results 
showed good separation and peak shapes with 14,000/m plate counts, or about 700 plates 
for the benzophenone peak using the 5 cm length column (Figure 5.2). 
 
 
 
Figure 5.2 Test of capillary column (50 mm x 0.5 mm i.d.) packed with Kromasil C18 
stationary phase using 50 mg material (~700 plate counts).  LC instrument:  Eksigent 
Nano LC.  Chromatographic conditions:  mobile phase A=0.1% phosphoric acid in water 
(pH 2), mobile phase B=acetonitrile, isocratic 40%A/60%B, 20 µL/min flow rate, column 
temperature set at 25 °C, 90 nL injection volume. 
 
 
 
The column packing efficiency was also tested with smaller amounts of stationary 
phase and a column packed with 10 mg stationary phase in 300 µL IPA showed 
Uracil
Benzophenone
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acceptable peak shapes with about 350 plates for the benzophenone peak using the 5 cm 
length column (Figure 5.3).  This test demonstrated that the custom-made slurry column 
packer could be used to pack small capillary columns with 0.5 mm i.d. using about 10 mg 
of RNA-modified stationary phases. 
 
 
Figure 5.3 Test of capillary column (50 mm x 0.5 mm i.d.) packed with Kromasil C18 
stationary phase using 10 mg material (~350 plate counts).  LC instrument:  Eksigent 
Nano LC.  Chromatographic conditions:  mobile phase A=0.1% phosphoric acid in water 
(pH 2), mobile phase B=acetonitrile, isocratic 40%A/60%B, 20 µL/min flow rate, column 
temperature set at 25 °C, 90 nL injection volume. 
 
 
 
5.4 Bonding strategies for the chemical synthesis of RNA-modified silica 
 
With the capillary column packer at hand, the bonding strategies for the chemical 
synthesis of RNA-modified silicas were considered next.  There are many different 
chemical strategies for attaching oligonucleotides to solid supports [9].  Carboxyl and 
amino groups are the most common reactive groups for attaching ligands to surfaces, 
which are stable and widely explored.  Amino groups can be easily attached to the 5’ or 
Uracil
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3’-end of an oligonucleotide and then can be reacted with carboxylate-modified 
stationary phases with carbodiimide chemistry (a one step process at pH 6-8), using 1-
ethyl-3-(3-dimethyl-aminopropyl)carbodiimide hydrochloride (EDAC) as an acylating 
agent (Figure 5.4). 
 
 
Figure 5.4 Covalent coupling of an amine-modified oligonucleotide to a carboxylate-
modified micro-sphere with water-soluble carbodiimide [9]. 
 
 
 
Other possible bonding strategies for the amino modified oligonucleotides include 
isothiocyanate forming thioureas (stable covalent attachment), succinimidyl esters (NHS-
esters) by forming very stable amide bonds, and sulfonyl chlorides which are less 
commonly used due to their instability in water (Figure 5.5). 
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Figure 5.5 Different possible chemical bonding strategies for the amino modified 
oligonucleotides, including isothiocyanate, succinimidyl ester, and sulfonyl chloride [9]. 
 
 
 
Another bonding strategy includes the copper-catalyzed azide-alkyne Huisgen 
cycloaddition mechanism, also known as ‘click chemistry’ (Figure 5.6) [10]. 
 
 
 
Figure 5.6 Copper (I)-catalyzed synthesis of 1,4-disubstituted 1,2,3-triazoles (‘click 
chemistry’) [10]. 
 
 
 
Furthermore, this more recently discovered click chemistry approach was 
successfully used for attaching small-molecule receptors onto silica gels [11].  In this 
approach, azido-modified silica gels were prepared in a two-step process including 
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surface pre-activation with haloalkylsilanes followed by a nucleophilic halide/azide 
exchange.  Having azido-modified silica, different alkyne-functionalized molecules were 
then attached to the silica gel by click chemistry.  This bonding strategy is simple, uses 
mild conditions, and could be one of the best approaches for bonding oligonucleotides 
onto silica gels for evaluation of RNA-modified affinity chromatography separation of 
oligonucleotides. 
 
5.5 Synthesis of RNA-modified silica stationary phases using solid-phase 
synthesis 
 
Click chemistry approach was selected as the bonding strategy for preparation of 
the RNA-modified silica stationary phases using solid-phase synthesis.  In this approach, 
azide functionality was first attached to the silica, and then reacted with RNA 
oligonucleotide containing alkyne functionality, using copper (I) as catalyst.  The first 
reaction step involved the preparation of azido-modified silica.  In this step, amino silica 
was reacted with azido-NHS-ester to form azido-modified silica (Figure 5.7).  The 
reaction was run at room temperature, and the reaction solvent was evaluated.   
Different solvents were evaluated, such as dimethylsulfoxide (DMSO), 
DMSO/water, dichloromethane (DCM), and acetonitrile (MeCN).  The results showed 
quick hydrolysis of the NHS-ester in any aqueous conditions, such as DMSO/water.  The 
NHS-ester also was not stable in DMSO and DCM and different impurities were 
generated.  These solvents can also dissolve the silica and hence were not a good reaction 
solvent choice.  Acetonitrile showed the best stability of the NHS-ester and conversion to 
azido-silica and anhydrous acetonitrile was chosen as the reaction solvent. 
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Figure 5.7 Azido-modified silica preparation reaction scheme. 
 
 
 
The azido-silica preparation reaction was monitored by a RPLC method.  The 
method used a Waters XBridge C18 column (150 mm x 4.6 mm i.d. and 3.5 µm particle 
size).  The mobile phase consisted of 5 mM ammonium phosphate buffer with pH 
adjusted to 6.8 (mobile phase A) and acetonitrile as organic modifier (mobile phase B).  
A linear gradient was used from 5%B to 95%B in 7 minutes, followed by 3 min post 
equilibration at 5%B.  The flow rate was 1.5 mL/min, column temperature at 25 °C, 
injection volume 5 µL (of about 1 mg/mL sample concentration), and UV detection was 
at 210 nm (Figure 5.8). 
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Figure 5.8 Azido-modified silica synthesis - reaction monitoring by RPLC method using 
Agilent 1100 LC instrument.  Chromatographic conditions:  Waters XBridge C18 column 
(150 mm x 4.6 mm i.d., 3.5 µm particles), mobile phase A=5 mM ammonium phosphate 
adjusted to pH 6.8, mobile phase B=acetonitrile.  A linear gradient was used from 5%B to 
95%B in 7 minutes, followed by 3 min post equilibration at 5%B.  The flow rate was 1.5 
mL/min, column temperature at 25 °C, injection volume 5 µL (of about 1 mg/mL sample 
concentration), and UV detection was at 210 nm. 
 
 
 
The reaction mixtures were prepared in a humidity controlled glove box with low 
0-2% relative humidity (RH), using 1.5 mL spin tubes that were tightly closed.  The tubes 
were then transferred to a sample shaker set at 25 °C temperature and 600 rotations-per-
minute (RPM).  Sample aliquots were withdrawn at certain time intervals to check for 
reaction completion.  At first, reactions were set and optimized at 10 mg scale, and later 
successfully scaled to 100 mg scale.  The azide-NHS-ester reagent was always charged in 
excess, and reaction monitoring showed reaction completion after 2 days for 10 mg scale 
(10 mg amino silica with 1 mL solution), and 6 days for the 100 mg scale (100 mg amino 
silica with 1 mL solution).  After reaction completion, the azido-modified silica was 
washed with anhydrous acetonitrile (triplicate) to remove any unreacted azide-NHS-ester, 
and dried before the next chemical step. 
The next synthesis step was click chemistry of azido-modified silica with an RNA 
single-strand.  The alkyne functionality required for the click chemistry was placed on 
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one of the nucleotides on the RNA strand, where the ribose sugar was modified with a 
propargyl group on the 2’-position (instead of the hydroxyl for the typical RNA 
nucleotide).  The copper (I) bromide dimethyl sulfide (Cu (I) Br Me2S) solution was 
prepared using anhydrous acetonitrile in the humidity controlled (0-2% RH) glove box 
(Figure 5.9).  This is important in order to prevent oxidation of the copper (I) catalyst.  
Initial results showed that there was no reaction in 100% anhydrous acetonitrile and room 
temperature click chemistry reaction conditions. 
 
 
 
Figure 5.9 Click chemistry reaction scheme for the preparation of RNA-modified silica. 
 
 
 
The critical reaction parameters, such as the reaction solvent, temperature, and 
mol% of the copper (I) catalyst were all evaluated (see Appendix B).  A summary of the 
reaction parameters tested are shown in Table 5.4.  In addition, control reactions (i.e., 
RNA oligonucleotide modified with a propargyl group in the reaction solvents tested and 
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in the absence of azido-modified silica) were also run in parallel to test for the rate of the 
reagent degradation vs. rate of reaction with azido-modified silica. 
 
 
Table 5.4 Critical reaction parameters including reaction solvent, temperature, and mol% 
of the copper catalyst in the click chemistry step were evaluated. 
 
Critical Reaction Parameters Conditions Evaluated 
 
Reaction Solvent 
50/50 v/v% 
water/acetonitrile 
80/20 v/v% 
water/acetonitrile 
100 % 
Water 
Reaction Temperature 25 °C 40 °C 60 °C 
Cu(I) catalyst mol% 2 mol% 10 mol% - 
 
 
 
The click chemistry reactions were monitored by an ion-pair reversed-phase 
liquid chromatography (IP-RPLC) method.  The method used a Waters XBridge C18 
column (150 mm x 4.6 mm i.d. and 3.5 µm particle size).  The mobile phase consisted of 
100 mM triethylammonium acetate (TEAA) in water with pH 7 (mobile phase A) and 
100 mM TEAA in acetonitrile as organic modifier (mobile phase B).  A segmented 
gradient was used from 5%B to 15%B in 8 minutes, then 15%B to 60%B in the next 2 
minutes to elute any late eluting impurities, followed by 5 min post equilibration at 5%B 
(total run time 15 minutes).  The flow rate was 1.5 mL/min, column temperature at 65 °C, 
injection volume 2 µL (of about 1 mg/mL sample concentration), and UV detection was 
at 260 nm (Figure 5.10). 
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Figure 5.10 Click-chemistry reaction monitoring by an IP-RPLC method using Agilent 
1100 LC instrument.  Chromatographic conditions:  Waters XBridge C18 column (150 
mm x 4.6 mm i.d., 3.5 µm particles), mobile phase A=100 mM TEAA in water (pH 7), 
mobile phase B=100 mM TEAA in acetonitrile.  A segmented gradient was used from 
5%B to 15%B in 8 minutes, then 15%B to 60%B in the next 2 minutes to elute any late 
eluting impurities, followed by 5 min post equilibration at 5%B (total run time 15 
minutes).  The flow rate was 1.5 mL/min, column temperature at 65 °C, injection volume 
2 µL (of about 1 mg/mL sample concentration), and UV detection was at 260 nm. 
 
 
 
Overall, the reaction conditions tested showed the best results with 50/50 
water/acetonitrile, 40 °C temperature, and copper catalyst loading at 10 mol%, although 
the reaction rate was relatively slow with reaction completion observed after 9 days.  
Using these conditions, the rate of conversion was as follows:  1
st
 day – 18%, 2nd day – 
30%, 3
rd
 day – 38%, 6th day – 68%, and 9th day - ~100% conversion.  The reaction 
conversion rate was increased slightly by changing the reaction solvent to 100% water 
(with 40 °C temperature and catalyst loading of 10 mol%), where reaction completion 
was observed after 6 days, however with significant degradation (Figure 5.11). 
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Figure 5.11 Click-chemistry reaction in 100% water solvent (40 °C temperature and 10 
mol% catalyst), reaction complete after 6 days but degradation was observed.  
Chromatographic conditions were similar as those in Figure 5.10. 
 
 
 
The reaction conversion rate was even further increased by increasing the 
temperature to 60 °C (using 100% water and catalyst loading of 10 mol %), where 
reaction completion was observed after only 3 days, however also with some degradation 
(Figure 5.12). 
 
 
 
Figure 5.12 Click chemistry reaction in 100% water solvent (60 °C temperature and 10 
mol% catalyst), reaction completion after 3 days but degradation was observed.  
Chromatographic conditions were similar as those in Figure 5.10. 
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Next, a few different click chemistry reactions were scaled up to 10 mg scale 
(50/50 water/acetonitrile solvent, 40 °C temperature, and 10 mol% copper catalyst 
loading) using 10-mer, 15-mer, and 21-mer RNA oligonucleotides with propargyl 
modification.  The synthesized materials were washed (triplicate) with 50/50 
water/acetonitrile and dried. 
In order to assess the RNA oligonucleotide loading onto the silica stationary 
phase, the newly synthesized RNA stationary phases were tested for phosphorus (P), 
which is present in the RNA molecule only, using inductively coupled plasma atomic 
emission spectroscopy (ICP-AES).  The ICP-AES for P analysis was performed by the 
Merck Metals Analysis Group.  The ICP-AES results for the 15-mer RNA reaction from 
Figure 5.10 showed 3700 ppm of P, which is equivalent to 0.008 mmol of RNA/g of 
silica loading (3700 µg P/g silica x 1 µmol P/31 µg P x 1 mmol P/1000 µmol P x 1 mmol 
RNA/15 mmol P = 0.008 mmol RNA/g silica).  The starting material of amino silica had 
0.2 mmol/g of NH2 loading, and initially 0.2 mmol of RNA/g of silica was expected if 
reactions were completed (as observed by the reaction monitoring RPLC methods).  
However, if we consider the significant differences in size (and surface area) of 
the NH2 residues (~1-2 Å) vs. the larger 21-mer RNA oligonucleotides (~ 50 Å), then a 
one 21-mer RNA oligonucleotide would occupy the same surface area as 25 of the NH2 
molecules on the surface of the silica stationary phase, thus theoretically obtaining (0.2 
mmol / 25) 0.008 mmol of RNA/g silica.  Furthermore, the calculated RNA loading for 
the non-optimal reaction conditions, such as in Figure 5.12 with degradation observed by 
LC, was about 0.006 mmol RNA/g silica (consistent with the LC results). 
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Based on these results, our bonding strategy using click chemistry of azido-
modified silica with propargyl modified RNA oligonucleotide using Cu (I) as catalyst 
was successful for the preparation of RNA-modified silica stationary phases and with 
good yields.  The reaction rates using conditions such as 50/50 water/acetonitrile, 40 °C 
temperature, and 10 mol% catalyst were relatively slow (~9 days), but afforded 100% 
conversion and with very high yields. 
 
5.6 Packing of capillary LC columns with new RNA-modified stationary phases 
and their preliminary evaluation for RNA-based affinity chromatography 
separation of oligonucleotides 
 
The newly synthesized RNA-modified silica stationary phase, consisting of 15-
mer RNA modification with the following 15-mer RNA:  5’-AUUGGUAUUCAGUGU-
3’, was packed into a small capillary 0.5 mm i.d. x 5 cm length column using the column 
packing apparatus in Figure 5.1.  The slurry mixture was prepared with 10 mg of RNA-
modified silica in 300 µL of IPA (sonicated for about 15 minutes).  The newly packed 
capillary column was then tested using the Eksigent Nano LC instrument and a RPLC 
method.  The RPLC method conditions consisted of 20 mM potassium phosphate buffer 
with the pH adjusted to 7 as the aqueous mobile phase A, and acetonitrile as the organic 
mobile phase B.  The method used gradient conditions of 10-90%B in 2 minutes, 20 
µL/min flow rate, column temperature at 25 °C, 300 nL injection volume, and UV 
detection set at 210 nm.  The test analyte was a mixture of uracil (used as a void marker) 
and benzophenone (1 mg/mL in 50/50 water/acetonitrile).  The test result showed 
reasonable peak shapes, and benzophenone was retained on the column and separated 
with almost baseline resolution from the uracil peak (Figure 5.13). 
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Figure 5.13 Test of capillary LC column packed with a 15-mer RNA-modified stationary 
phase using Eksigent Nano LC instrument.  The RPLC method conditions consisted of:  
20 mM potassium phosphate buffer with pH adjusted to 7 as the aqueous mobile phase A, 
and acetonitrile as the organic mobile phase B.  The method used gradient conditions of 
10-90%B in 2 minutes, 20 µL/min flow rate, column temperature at 25 °C, 300 nL 
injection volume, and UV detection set at 210 nm.  The test analyte was a mixture of 
uracil (used as a void marker) and benzophenone (~1 mg/mL concentrations in 50/50 
water/acetonitrile). 
 
 
 
The 15-mer RNA-modified column was then evaluated with a complementary 10-
mer RNA analyte:  5’-GAAUACCAAU-3’ using the above RPLC method (Figure 5.14).   
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Figure 5.14 Analysis of a complementary 10-mer RNA analyte using the 15-mer RNA-
modified stationary phase with Eksigent Nano LC.  Chromatographic conditions were 
similar as those in Figure 5.13. 
 
 
 
Initial results of the 10-mer analyte showed no elution from the 15-mer RNA-
modified column.  This could be due to strong binding of the 10-mer RNA analyte with 
the complementary 15-mer RNA attached to the silica stationary phase.  Next, the 
column temperature was increased to 40 °C, but there was still no elution of the 10-mer 
analyte.  Then, other shortmer samples such as 9-mer to 6-mer RNA analytes were 
injected in the column, but the results were not reproducible, possibly from a rapid 
degradation of the RNA stationary phase. 
 
5.7 Conclusions 
Oligonucleotide mixtures consisting of short RNA samples are often highly 
complex and very difficult to separate.  The possibility of selective binding of target 
oligonucleotides for the separation and purification of oligonucleotides by RNA-based 
affinity chromatography could be a very useful approach.  This hypothesis was explored 
by successfully preparing RNA-modified stationary phases which were packed into small 
capillary LC columns.  The preliminary investigations, however, showed that the RNA-
Complementary 10-mer RNA Analyte
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based stationary phases for selective purification of short RNA sequences bind strongly 
with the complementary RNA analytes, which do not elute from the column.  The RNA-
modified stationary phase also seemed to quickly degrade at elevated column temperature 
of 40 °C, a problem that could potentially be solved by the use of more thermostable 
DNA-based stationary phases, or the use of RNAs with typical 2’-fluoro or 2’-methoxy 
modifications, or even the use of complementary phases based on peptide nucleic acids 
(PNAs) [12], which are significantly more thermostable than either RNA or DNA, but 
retain the ability to form complementary duplexes. 
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Chapter 6: Conclusions and Thoughts for Additional Improvements for Analysis of 
Short RNA Oligonucleotides 
6.1 Conclusions 
As part of antisense and siRNA drug development, there has been a tremendous 
growth in the research and applications of oligonucleotides during the last decade.  
Oligonucleotides represent one of the most significant pharmaceutical breakthroughs that 
have the potential to revolutionize biomedical research.  These fascinating compounds 
have emerged as potential candidates for the treatment of a wide range of diseases, 
including cancer, cardiovascular disease, viral infections, and many other degenerative 
disorders. 
Most of the research efforts in this area have focused on the understanding of the 
chemistry and biology for the different mechanisms of action of oligonucleotides.  The 
development of analytical methods for the sensitive and quantitative analysis and 
separation of oligonucleotides is an essential part for the advancement of this research 
area.  A typical oligonucleotide therapeutic sample is a short RNA-based oligonucleotide 
with about 21-mer chain length (~7-8 kDA), and with possible chemical modifications 
prepared by chemical synthesis using an automated synthesizer.  Due to their relatively 
large sizes and highly negative charges compared to typical small-molecule compounds, 
oligonucleotides can be difficult to analyze with traditional analytical methods used for 
small molecules.  There are many different analytical techniques reported for the analysis 
and separation of oligonucleotides, including CGE, AEX-HPLC, and IP-RPLC. 
The goal of the research studies presented here was to evaluate and improve 
existing liquid chromatography methods and explore new and novel approaches for more 
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efficient analysis and separation of oligonucleotides.  First, IP-RPLC methods using 
either TEAA or HFIP-TEA mobile phases were evaluated for analysis of 
oligonucleotides.  While TEAA-based LC methods provided excellent separation, 
including some separation of the more challenging full-length sequences, using UV-
based detection methods, HFIP-TEA methods provided excellent separation of 
oligonucleotides for MS detection.  Additionally, core-shell type columns, which are 
extensively used for small molecule separations, were evaluated for improved 
oligonucleotide separations.  The results showed significant improvement for separation 
of closely related impurities and faster run times when using core-shell type columns 
compared to fully-porous particles.  The long-term column stabilities, however, were an 
issue when operating at neutral pH and elevated column temperatures.  A new core-shell 
type column, SunShell C18, with purported greater stability at high pH and high column 
temperatures due to a special end-capping chemistry, showed similar separation 
efficiency as the previously evaluated core-shell columns, but with significantly higher 
column stability, making this method a more practical analytical approach for analyzing 
hundreds of oligonucleotide samples. 
In order to obtain full characterization of oligonucleotides, often both analytical 
methods, IP-RPLC and AEX-HPLC, need to be utilized.  Very few previous studies have 
shown the advantage of using mixed-mode columns, consisting of anion-exchange and 
reversed-phase, for improved separation of oligonucleotides.  As part of our research, we 
performed an extensive evaluation of recently commercialized Scherzo mixed-mode 
columns for improved analysis and separation of oligonucleotides.  The results showed 
excellent separation of the common N-x deletion impurities, as well as the more 
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challenging oligonucleotides with very subtle differences in their sequences, when using 
the Scherzo SW-C18 or SM-C18 columns with typical AEX-HPLC method conditions, 
such as elution with NaCl salt gradient.  These results also showed the benefit of 
combining both methods into a single analytical method. 
Finally, affinity chromatography based on RNA-modified columns was 
considered and explored for the affinity separation of oligonucleotides.  RNA-modified 
stationary phases were successfully synthesized using a click chemistry approach.  The 
newly synthesized RNA-modified stationary phases were packed into small capillary LC 
columns with 0.5 mm i.d. using a custom-built column packer and tested using a nano LC 
instrument.  The preliminary results, however, showed that complementary RNA analytes 
bind strongly with the RNA-modified column and they do not elute from the column.  
The results also showed quick degradation of the RNA-modified stationary phase when 
used for affinity chromatography separation of oligonucleotides. 
The results obtained from our oligonucleotide research provide improvements to 
current oligonucleotide analytical approaches using IP-RPLC and new approaches for 
successfully using mixed-mode columns.  New and novel affinity chromatography 
approaches can also be further explored using the RNA-modified stationary phases 
reported here. 
 
6.2 Suggestions for further improvements 
The use of more stable DNA-based stationary phases, or RNAs with 2’-fluoro or 
2’-methoxy modifications, or even complementary phases with peptide nucleic acids 
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(PNAs)
 
, which are significantly more stable while retaining the ability to form 
complementary duplexes, may be more useful approaches for the RNA-based affinity 
chromatography separations of oligonucleotides and can be further explored in the future. 
  
154 
 
Appendix A:  Evaluation of Base-Flip Isomers at Different Column Temperatures 
 
 
Overlaid Chromatograms (from bottom-to-top):  blank, 21-mer Apo-B1, Isomer 1, 
Isomer 2, Isomer 3, Isomer 4, and Isomer 5. 
Column Temperature:  65 °C 
 
 
Column Temperature:  55 °C 
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Column Temperature:  45 °C 
 
 
Column Temperature:  35 °C 
 
 
Column Temperature:  25 °C* 
 
*Note that there was no isomer 5 injected in this run, there was no sample left in the vial. 
Base-Flip Isomers (See Table 4.2).  In each isomeric oligonucleotide the order of two 
neighboring bases has been reversed.   
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Sample RNA Sequence 
21-mer 5'-GUCAUCACACUGAAUACCAAU-3' 
Isomer 1 5'-UGCAUCACACUGAAUACCAAU-3' 
Isomer 2 5'-GUCACUACACUGAAUACCAAU-3' 
Isomer 3 5'-GUCAUCACACGUAAUACCAAU-3' 
Isomer 4 5'-GUCAUCACACUAGAUACCAAU-3' 
Isomer 5 5'-GUCAUCACACUGAAUACCAUA-3' 
 
Note that 12-18 min portions of chromatograms are shown to zoom in on the peak elution 
areas.  IP-RPLC method conditions:  XBridge C18 column (150 mm length x 4.6 mm i.d. 
and 3.5 µm particle size).  The mobile phase consisted of 100 mM TEAA in water 
(mobile phase A), and 100 mM TEAA in acetonitrile (mobile phase B).  A standard 
linear gradient method of 5-10% mobile phase B over 15 minutes, hold at 10%B for 5 
minutes, with 5 minutes post column equilibration at 5% B was used.  The flow rate was 
1.5 mL/min, injection volume was 15 µL, and UV detection was set at 260 nm. 
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Appendix B:  Evaluation of Different Reaction Conditions for RNA Click-
Chemistry with Azido-Modified Silica 
 
 
Click Chemistry with different 
RNA Oligonucleotides 
1 mg scale 
Reaction Conditions Evaluated 
  
Observed Results 
(Overlaid Chromatograms:  from bottom-to-top order is blank, 21-
mer RNA after click reaction, 21-mer RNA before click reaction). 
Reaction Solvent: 
50:50 water:acetonitrile 
Temperature:  25 °C 
Cu(I) Catalyst:  2 mol% 
 
No reaction (1 Day) 
10-mer RNA 
 
 
Reaction Solvent: 
50:50 water:acetonitrile 
Temperature:  25 °C 
Cu(I) Catalyst:  10 mol% 
3% Conversion, 1 Day (Very slow) 
10-mer RNA 
 
 
 
Reaction Solvent: 
50:50 water:acetonitrile 
Temperature:  40 °C 
Cu(I) Catalyst:  2 mol% 
27% Conversion, 5 days 
21-mer RNA 
 
 
 
 
 
 
 
 
 
Reaction Solvent: 
50:50 water:acetonitrile 
Temperature:  40 °C 
Cu(I) Catalyst:  10 mol% 
71% Conversion, 5 days 
21-mer RNA 
 
 
100% Conversion, 9 days 
15-mer RNA 
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Reaction Solvent: 
80:20 water:acetonitrile 
Temperature:  40 °C 
Cu(I) Catalyst:  2 mol% 
 
84% Conversion, 5 days 
21-mer RNA 
 
 
 
Reaction Solvent: 
80:20 water:acetonitrile 
Temperature:  40 °C 
Cu(I) Catalyst:  10 mol% 
99% Conversion, 5 days 
21-mer RNA 
 
 
 
 
 
 
 
 
Reaction Solvent: 
100% water 
Temperature:  40 °C 
Cu(I) Catalyst:  10 mol% 
 
77% Conversion, 3 days 
21-mer RNA 
 
 
97% Conversion, 6 days 
21-mer RNA 
 
 
 
Reaction Solvent: 
100% water 
Temperature:  60 °C 
Cu(I) Catalyst:  10 mol% 
99% Conversion, 3 days 
15-mer RNA 
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The click chemistry reactions were monitored by an ion-pair reversed-phase liquid 
chromatography (IP-RPLC) method.  The method used a Waters XBridge C18 column 
(150 mm x 4.6 mm i.d. and 3.5 µm particle size).  The mobile phase consisted of 100 mM 
triethylammonium acetate (TEAA) in water with pH 7 (mobile phase A) and 100 mM 
TEAA in acetonitrile as organic modifier (mobile phase B).  A segmented gradient was 
used from 5%B to 15%B in 8 minutes, then 15%B to 60%B in the next 2 minutes to elute 
any late eluting impurities, followed by 5 min post equilibration at 5%B (total run time 
15 minutes).  The flow rate was 1.5 mL/min, column temperature at 65 °C, injection 
volume 2 µL (of about 1 mg/mL sample concentration), and UV detection was at 260 nm. 
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